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ABSTRACT

Differential Alterations of Key Cytokine Production by
Aflatoxin B1 and T-2 toxin in Male CD-1 Mice

by

Raviprakash R. Dugyala, Doctor of Philosophy
Utah State University, 1995

Major Professor: Dr. Reed P. Warren
Program: Toxicology

Aflatoxin B, and T-2 toxin are mycotoxins, which produce their
immunotoxic effects by affecting nonspecific and acquired immunity in different
species. The mechanisms of their immunotoxicity are still obscure. Cytokines
are the key signaling molecules during the immune response.

In this study,

expression of macrophage-produced cytokines Interleukin-la (IL-la), tumor
necrosis factor (TNF), and IL-6, and lymphocyte-produced cytokines IL-2,
interferon y (IFNy), and IL-3 was measured at the mRNA and protein levels, after
in vitro activation with rnitogens in AFB,- and T-2-toxin-exposed mice.
Significant changes in the organ weights, especially in the mice exposed to
a high dose of T-2 toxin, and no effect in AFB,-exposed mice were observed.

iv
ConA-induced production of IL-2, IFNy, and IL-3 mRNA and protein
levels in AFB1-exposed mice showed a decrease in low dose groups (significant
for IL-2 mRNA), but no change at other doses. However, in T-2-toxin-treated
animals, there was a significant induction of IL-2 and IFNy mRN A in high and
low doses and of IL-3 mRNA at the medium dose. The protein levels of IL-2 and
IFNy did not follow the mRNA levels in high dose and the protein levels of IL-3
were significantly increased in medium and low doses.
Lf-'5-induced IL-la and TNF mRNA and protein levels in AFB1-exposed
mice were suppressed at the high dose while mRNA levels of both cytokines
were increased significantly in the low and medium doses. Low and medium
doses of AFB1 also significantly decreased IL-lu protein levels and the high dose
decreased IL-6 protein. In T-2 toxin-treated mice, no significant difference in
mRNA levels of these cytokines was observed but a general pattern of significant
suppression of their protein levels (except IL-la at medium dose) showed that
both toxins regulate the cytokine expression differently.
Based on the above discussed results and others, AFB1 may alter cellmediated immunity by affecting the communication between macrophages and
T lymphocytes through inhibiting the macrophage-producing cytokines.
toxin-induced immunosuppression may be due not only to the inhibition of

T-2

v

macrophage-producing cytokines, but also to the lack of effector cells to respond
to the cytokines (IL-2, IFNy, and IL-3).
(153 pages)
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CHAPTER I
INTRODUCTION AND LITERATURE REVIEW

Immunotoxicology is the discipline of toxicology devoted to the study of
the immune system as a target for the toxicity of xenobiotics, drugs, and
chenticals. This area is recently receiving a great deal of attention because a
number

of

xenobiotics,

drugs,

and

chemicals

are

proven

to

be

immunomodulators. The immune system is very complex; it consists of a large
number of different types of cells that are rapidly proliferating in a highly
organized network. This network is very sensitive to several external factors.
Any imbalance in the system may lead to immunosuppression, allergy,
autoimmunity, or cancer.

Cytokines or interleukins (ILs) are soluble factors

produced by macrophages, T lymphocytes, and other cell types of the body
when they are activated by specific antigens.

They are the key signaling

molecules between the immune cells and act in that microenvironment to help in
the development of acquired immunity. Any modulation in the production of
ILs will lead to either immunosuppression or immunostimulation. Results from
the use of immunosuppressive drugs such as cyclosporin A and FK506, which
are known to suppress the production of cytokines, suggest that mycotoxins,
which are also immunomodulators, might cause immunotoxicity by interfering
with the production of cytokines.
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CYTOKINES AND THEIR ROLE
IN THE IMMUNE RESPONSE
Cytokines are soluble factors produced by macrophages, T lymphocytes,
and other cell types of the body when they are activated by specific antigens.
Macrophages produce cytokines such as IL-l (IL-Ia and !L-Ip), IL-6, and tumor
necrosis factor (TNF) (Akira et al., 1990). There are two different subtypes ofThelper cells: THl cells that produce IL-2 and interferon y (IFNy) and TH2 cells that
produce IL-4 and IL-10; IL-3 is produced by both cell types (Mosmann and
Coffman, 1989). Cytokines play very important roles in promoting ceil growth,
differentiation, and functional activation of immune cells. These growth and
differentiation factors act on different cell types by autocrine or paracrine activity
to help clear the antigens in different ways.

Current research indicates that

cytokines are not restricted to one specific function but are multifunctional
molecules with a variety of activities, some of which are overlapping with those
of other cytokines.

This kind of pleiotropy and redundancy of cytokines is

exerted not only on the immune cells but also on many target cells and tissues,
including even the nervous system (reviewed by Mizel, 1989).
Macrophages or monocytes are important in the regulation of humoral
and cell-mediated immunity apart from their phagocytic and cytotoxic action
against foreign invaders. When foreign antigens enter the body, they are taken
and processed by macro phages and presented to T cells, thereby activating the T

3

cells. In this process, macrophages produce cytokines like IL-l (IL-la and

-1~),

IL-6, and TNF, and activated T lymphocytes (mainly T-helper cells) produce IL-2,
IL-3, and IFN (reviewed by Mizel, 1989; Germain, 1994). These growth and
differentiation factors act on different cell types by autocrine or paracrine
pathways to make them more effective in clearing the antigens in different ways;
these will be addressed briefly and individually.

Inter/eukin-1.

Interleukin-1 (mainly derived from macrophages) is the

term for the two polypeptides (IL-la and

IL-l~)

inflammatory,

hematopoietic,

metabolic,

physiologic,

that have a wide spectrum of
and

immunologic

properties. IL-l is initially synthesized as a 33-kDa precursor, and subsequently
processed to 13-17 kDa (Mizel, 1989). IL-1 participates in the mechanisms ofT
and B cell activation; its receptors are not expressed in the resting lymphocytes.
The T cell activating property of IL-l is measured by it's ability to act in a costimulator assay with sub-optimal concentrations of antigens or mitogens
(Dinarello, 1992). IL-l amplifies T cell activation by inducing expression of IL-2
and IL-2R genes, particularly in conjunction with mitogens, antigens, calcium
ionophores, or stimulators of protein kinase C (Simic and Stosic, 1985). IL-l,
along with IL-4, also acts as a helper or co-factor during the activation process of
B cells and Ig production.

It also affects hematopoiesis by inducing the

production of GM-CSF, C-CSF, M-CSF, and IL-3; it acts synergistically with CSFs
and other cytokines on hematopoiesis (Bagby, 1989).

4

lnterleukin-6.

Interleukin-6

is

a cytokine

mainly

produced

by

macrophages, with pleiotropic activities that play a central role in host defense.
It is a glycoprotein with a molecular mass in the range of 20-30 kDa, depending
on the cellular source and preparation (Akira et al., 1993). IL-6 acts mainly on the
late phase of the B cell differentiation pathway, consistent with the finding that
interleukin-6 receptor is expressed on activated B cells but not resting B cells
(Taga et al., 1987). It acts on mitogen-activated B cells to induce IgM, IgG, and
IgA production without stimulating B cell proliferation (Muraguchi et al ., 1988;
Beagley et al., 1989).

IL-6 synergizes with IL-l for T cell proliferation and

cytotoxic T lymphocyte generation via induction of IL-2 (Houssiau and Van
Snick, 1992). IL-6, along with IL-3, induces proliferation and differentiation of
bone marrow progenitor stem cells (Suzuki et al., 1989); it also enhances
phagocytosis and expression of a number of macrophage differentiation
antigens, including Mac-1 and Mac-3, major histocompatibility complex class I,
nonspecific esterases, lysozyme, 2',5'-A-synthetase, and C-frns, indicating the
functional differentiation into mature macrophages (Akira et al., 1993).

Tumor necrosis factor. Tumor necrosis factor is largely produced by
macrophages, and plays an important role in the defense against viral, bacterial,
parasitic, immune, and autoimmune diseases.

Tumor necrosis factor is

synthesized as a precursor protein of 26 kDa, which is processed to a secreted 17
kDa (McGeeham et al., 1994). The pleiotropic effects of TNF include cytostatic
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and cytotoxic activity on malignant cells and cells infected by viruses or bacteria.
It is also involved in the induction of cytotoxic T lymphocytes, enhancement of
the killing activity of macrophages and natural killer (NK) cells, and activates the
immune system by the generation of cytokines (IL-2, IL-7, IL-12) (Fiers, 1991).

Interleukin-2.

Interleukin-2 plays a more pivotal role in initiating and

potentiating the immune response than any other lymphokine secreted by T
lymphocytes. It provides a critical signal necessary for both T cell proliferation
and antibody secretion by B cells. As deduced from the eDNA sequence, the
mature murine IL-2 contains 149 amino acids and molecular weights range from
15.5 to 31 kDa (Kashima et al., 1985). The mechanism of IL-2 activation ofT cells
is the best understood among all known cytokines (Taniguchi and Minami,
1993).

Interleukin-2

also

helps

in

long-term growth and

functional

responsiveness of antigen-specific CTL clones (Gillis and Smith, 1977). It also
induces the IL-2 receptor expression in T cells and acts on NK cells and
monocytes (Smith and Cantrell, 1985; O'Garra et al., 1988).

Interleukin-3.

Interleukin-3

is a T lymphocyte-derived

28 kDa

glycoprotein that contains 38% carbohydrate. The murine IL-3 gene encodes a
protein of 166 amino acids.

The first 26 amino acids encode a typical

hydrophobic leader sequence required for secretion (Fung et al., 1984).
Interleukin-3 activates macrophages in different ways. Morphological changes
and increased phagocytosis in IL-3-activated peritoneal macrophages were

6
reported (Crapper et al., 1985). Interleukin-3 also induces Ia and the class II
molecule LFA-1 expression in macrophages, thereby increasing the antigen
presenting capacity to T-helper cells but not cytotoxicity (Frendl and Beller,
1990).

Production of IL-l, IL-6, and TNF in macrophages is dramatically

increased by the exoposure of peritoneal macrophages to IL-3, showing that IL-3
is one of the key elements in macrophage activation (Frendl, 1992).
Interferon y.

Interferon y is produced by T lymphocytes, including

helper/ suppressor phenotypes (Kasahara et al., 1983). The protein contains 143
amino acids with a molecular weight ranging from 20 to 25 kDa. Although lFNy
is best known for inducing anti-viral activity, it can also modulate the function of
a number of cell types important in the immune response (Friedman and Vogel,
1983). IFNy plays a key role in the activation ofT cells by stimulating increased
expression of the IL-2R, which allows the continued proliferation of T cells in
response to IL-2. In turn, the T cell response to IL-2 enhances the production of
IFNy (Farrar et al., 1986), thereby creating an interdependent network ofT cell
responses, which allows the continued production of soluble factors.

This

network increases tumor killing activity, phagocytosis, and induction of class II
major histocompatibility antigen complex (!a) in macrophages, and activation
and growth enhancement of CTL-cells and NK-cells (Trincheiri and Perussia,
1985). IFNy is also known to induce oxygen-dependent, or respiratory burstdependent microbicidal activity in the macrophage (Sasada and Johnson, 1980),
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and oxygen-independent macrophage activity by enhancing indole amine 2, 3dioxygenase (100) activity (Pfefferkorn, 1984).
The summary of the above discussed cytokine communication network
during immune response is illustrated in Figure I-1 .

REGULATION OF CYTOKINE GENE EXPRESSION
From the above discussion, it is clear that cy tokines are very crucial
signals for the development of the immune response. A single cytokine shows
pleiotropism by acting on different targets, and different cytokines demonstrate
redundancy by acting on the same target, showing similar effects. This is the
main reason cytokines are regulated tightly at the transcriptional and
translational levels: otherwise, the overproduction or underproduction of any
particular cytokine would be very harmful to the body.

For example,

overproduction of TNF and IL-1 causes severe pathological symptoms such as
inflammatory autoimmune diseases, one example of which is rheumatoid
arthritis (Brennan and Feldmenn, 1992). Immunosuppressive effects of drugs
such as cyclosporin A are mainly due to their effect on the down-regulation of
IL-2 and other cytokines (Hess et al., 1988). Regulation of cytokine expression
may occur at the transcriptional, post-transcriptional, translational, or posttranslational levels.
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Fig. I-1. The cytokine communication network during immune response.
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Cytokine genes, like many other eukaryotic genes, contain regu latory

elemen ts such as promoters, enhancers, and silencers.

These elements are

composed of discrete DNA sequences called cis-acting elements, which are
binding sites for sequence-specific DNA binding proteins called trans-acting
proteins.

These cis-acting elements are generally directly upstream of the

promoter and the two elements act in concert to achieve a fine degree of control
over the transcriptional activity of the cytokine genes. Trans-acting factors such
as NFAT

(~uclear

_Eactor of Activated

I cells), AP-1, AP-3, NF-KB

(~uclear

_Eactor-!;appa !l_), NF-IL6 and OBP (OCT-1 !l_inding froteins) bind to the upstream
regions of the promoters of cytokine genes and regulate the intiation of the
transcription in a differential way (Riegel et al., 1992; Chen-kiang et al., 1993; Rao,
1994). Many immunosuppressive drugs such as cyclosporin A and FK506 are
known to repress the induction of the transcription factors, thereby preventing
the transcription of the cytokines (Emmel et al., 1989; Brabletz et al., 1991).
Post-translational mechanisms involving factors regulating the mRNA
stability also play important roles in the gene regulation of cytokines. This is a
very active area of research that remains unclear. Reiterated AUUUA pentamers
(ARE) found within the 3'-untranslated regions (UTR) of IL-la, IL-1P, IL-2, IL-3,
TNF, IFNy, G-CSF, and GM-CSF appear to function as cis-regulatory elements
capable of regulating both the turnover and translation of these cytokines (Shaw
and Karmen, 1986; Han et al., 1990; Henics et al., 1994;).

This cis-regulatory

10
element appears to control the mRNA stability both positively and negatively by
binding to different AU-rich sequence binding proteins (AUBP).

In IL-2, AUBP

bind directly to the AU-rich 3' -UTR and increase the stability of mRNA in tumor
cells (Henics et al., 1994).

However, Cockfield et al. (1993) argued in their

discussion that cycloheximide-induced superinduction of IFNy and TNF is due to
its inhibition of synthesis of labile RNase proteins responsible for the
degradation of mRNA targeting the AU-rich region. Further studies are ongoing
to characterize different types of AUBP and their role in the regulation of
turnover and translation of cytokine mRNAs.
Initiation of translation of regulatory proteins (growth factors, cytokines,
etc.) is influenced by the different aspects of the mRNA structure: m7G cap, the
primary sequence or context surrounding the AUG codon, leader length, and
secondary structure both upstream and downstream of the AUG codon (Kozak,
1991). AU-rich 3'-UTR region in TNF is necessary for its efficient translation in
endotoxin-treated AU-rich 3'-UTR constructs containing cell lines (Han et al.,
1990); this shows that secondary structural features of mRNA at the 3' -UTRs are
very important for the efficient translation of these cytokines.
Production of interleukin-la and TNF is also regulated at the processing
and secretion levels. IL-la and

IL-l~

do not possess a typical NH2-terminal

hydrophobic secretory signal sequence to translocate directly into the cytoplasm
via the classical exocytic secretory pathway (Giri et al., 1985). As a consequence,

11
the newly .synthesized IL-Ia precursor proteins are localized in the cytoplasm:
There they are cleaved by the proteolytic enzyme calpain and undergo a
conformational change that exposes a required secretory signal causing their
secretion upon activation by a subsequent activation signal (Carruth et al., 1991;
Hazuda et al., 1991; Siders et al., 1993).

Pentamidine, an aromatic diamine

currently used to treat Pneumocystis carinii, specifically inhibits the cleavage of
pro-IL-1a and inhibits its secretion (Rosenthal et al., 1991). A similar kind of
inhibition of cleavage of pro-TNF into the secreted form is also observed with t.9tetrahydrocannabinol, a major psychoactive component of marijuana, in a mouse
macrophage cell line (Fischer-Stenger et al., 1993).

GENERAL TOXICOLOGY OF AFLATOXIN
B, AND T-2 TOXIN
Aflatoxins (AFs) are produced by several strains of aspergillus, especially
A. jlavus and A. Parasiticus, that grow on food crops.

The parent AFs, all of

which occur naturally, are a group of structurally related compounds that
possess a coumarin nucleus fused to a bisfuran moiety and either a pentanone,
such as in AFB, and AFB 2 , or a six-membered lactone, as in the case of AFG, and
AFGz (Figure I-2). Aflatoxin M, and AFM, are hydroxylated forms of AFB1 and
AFB,.

Aflatoxin B,a and AFG,a are 8, 9-hydrated products of AFB, and AFG1

(Coulombe, 1991; McLean and Dutton, 1995). Aflatoxin B1 is usually found in the
highest concentrations, followed by AFG1, AFB,, and AFG,. The order of acute
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and chronic toxicity is AFB 1>AFG1>AFB 2>AFG, (Wogan, 1966), reflectin g the role
played by epoxidation of the 8, 9-double bond and the greater potency associated
with the cyclopentinone ring of the B series, when compared with the 6membered lactone ring of the G series.
Aflatoxicosis caused by AFB1and related toxins represents one of the most
serious diseases of man, as well as poultry, livestock, and other lower animals
such as rat and mouse. Acute aflatoxicosis in poultry causes hemorrhages in
man y tissues, decreases egg production, and causes anorexia, stunting, and
hepato toxicosis with icterus. Microscopically, evidence of hepatotoxicosis has
included parenchymal degeneration with vacuolation, biliary hyperplasia, and
necrosis followed by cirrhosis. Low concentrations have been reported to cause
weakness and decreased resistance to disease, and have induced carcinogenesis
in many species (Newberne and Butler, 1969; Edds, 1973; Mollenhauer et al.,
1989). One important property of AFB1 is its mutagenicity and ca rcinogenicity.
Aflatoxin B1 causes hepatoma and other tumors in a variety of animal species
(Robens and Richard, 1992). A number of epidemiological investigations have
also implicated its role in the etiology of human liver cancer (Van Rensberg et al.,
1985; Yeh et al., 1990). The chemical activity of AFB1 is thought to proceed via the
formation of the 8, 9,-epoxide that can react with DNA and RNA to form a
covalent adduct at the N7 position of guanine residues (Croy et al., 1978). The
dihydrodiol form of AFB,, which is the hydration product of AFB1-8, 9, epoxide,

forms a schiffs base with amino groups of the bases (Hsieh, 1987).
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These

interactions of AFB, with macromolecules will definitely affect their biosynthesis
and increase possible mutations, which may induce cancer. Aflatoxin B, has been
demonstrated to activate the Ki-ras gene in rat liver. In this regard, in the final
stages of AFB,-induced rat liver hepatocellular carcinoma (HCC), two activating
mutations in the codon 12 region of Ki-ras genes [GGT to GAT (McMahon et nl.,
1987) and GGT to TGT (Sinha et al., 1988)] have been identified. Soman and
Wogan (1993) have confirmed the Ki-ras codon 12 GGT to GAT mutation in rat
liver, suggesting the involvement of this genetic mutation in the development of
AFB 1 -induced HCC in rats. Mutation in the third base of the codon 249 (G toT)
in p53 tumor suppression gene has been shown in Chinese patients ex posed to
aflatoxin (Hsu et al., 1991). However, there is a controversy involving these facts:
Because these mutations do not correlate with the human HCC, there may be
some other etiologic factors such as HBV infection also involved in the
development of these liver cancers (Nose et al., 1993).
Macromolecular syntheses such as DNA, RNA, and protein are also
shown to be affected by AFB 1. Covalent binding of AFB, to DNA leads to the
modification of DNA template activity and/or inactivation of certain enzymes in
DNA synthesis (Hsieh, 1987). RNA polymerase II activity and synthesis of rat
liver RNA, especially nucleolar RNA synthesis, are inhibited by AFB, (Yu, 1977).
RNA chain elongation and post-transcriptional processing of nuclear RNA are

15
also shown to be inhibited by the AFB, (Yu, 1981; Harley eta/., 1969). Inhibition
of protein synthesis by AFB, may arise directly from inactivation of biosynthetic
enzymes, or inhibition of translation, and/ or interference with arninoacid
transport (Hsieh, 1987). Disrupted membranes of endoplasmic reticulum due to
the direct damage by AFB, may interfere with ribosome binding, and protein
synthesis may be stopped (Terao and Ueno, 1978).
T-2 toxin is a secondary metabolite produced by Fusarium tricinctum,
which grows on such crops as corn (Sharma and Salunkhe, 1991). It belongs to
the family of mycotoxins called trichothecenes, and contains a common
trichothecene skeleton with cyclopentane, cyclohexane, and a 6-membered
oxyrane ring with four methyl groups. The skeleton contains an epoxide ring at
C-12, 13 and a double bond at C-9, 10, characterized as 12, 13-epoxytrichothec-9ene and are important for the trichothecene toxicity (Sharma and Kim, 1991).
The numbering system is shown in Figure 1-3. The trichothecenes are divided
into simple and macrocyclic trichothecenes, depending on the presence of a
macrocyclic ring linking at C-4 and C-5 with diesters or triesters.

Simple

trichothecenes are again divided into three types, namely type A, B, and C. Type
A trichothecenes include T-2 toxin, neosolaniol, HT-2 toxin, and others. Type B
trichothecenes, characterized by the presence of a ketone group in the C-8

16

16

15
14
Fig. I-3. The numbering system of trichothecene.
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position, include nivalenol, fusarium-X, and deoxynivalinol (Table 1-1) (Sharma
and Kim, 1991).
One of the best known human diseases associated with the trichothecenes
in humans is alimentary toxic aleukia (Joffe, 1978). This disease may be divided
into four stages clinically.

Shortly after ingestion of contaminated food,

symptoms such as burning sensation of mouth, tongue, throat, palate,
esophagus, and stomach are evident due to the toxin's inflammatory action on
the mucus membrane. Progressive leukopenia and granulopenia in the second
stage will render the body susceptible to infections. Continuous intake of the
toxin will cause petechial hemorrhages on the skin in the third stage followed by
necrosis in tonsils and throat, causing angina in the final stage. Recently another
human toxicosis in China was reported due to the ingestion of moldy rice
contaminated with T-2 toxin (Wang et al., 1993b).

The main symptoms are

nausea, dizziness, vomiting, chills, abdominal distention and pain, thoracic
stuffiness, and diarrhea.
Gross and pathological changes are also observed in various large and
laboratory animals treated with T-2 toxin. Swines treated with 0.6 to 5.4 mg
(single dose) per kilogram body weight showed gross and microscopic changes
(Pang et al., 1987). Gross lesions include edema, congestion, hemorrhage of the
lymph

nodes,

pancreas,

gastrointestinal

mucosa,

subendocardium,

etc.

Microscopic lesions include degeneration and necrosis of lymphoid tissues and
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TABLE 1-1

Structures of selected trichothecenes
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epithelium of gastrointestinal mucosa, mild scattered necrosis of pancreatic cells,
myocardium, bone marrow cells, adrenal cortical cells, and tubular epithelium of
renal medulla. These findings suggested that T-2 toxin damages both rapidly
dividing and nondividing cells. Oral exposure of male CD-1 mice with T-2 toxin
(2.5 mg/kg) for 2-4 weeks also led to ulcerations, lymphocyte infiltration,
epithelial proliferation, and hyperkeratinization of the forestomach (Taylor eta/.,
1989).
T-2 toxin is cytotoxic to many cell types, causing damage to the tissues.
Mice treated with T-2 toxin (0.30 mg/kg) had decreased bone marrow cellularity,
suggesting that extremely small doses of T-2 toxin can produce a significant
degree of bone marrow cytotoxicity (Faifer eta/., 1992). Hypocellularity of CD4+
and CDS+ T cells in thymus and T cells in spleen are observed in T-2-toxintreated mice (Smith et a/., 1994), suggesting that T-2 toxin can be cytotoxic to
specific subsets of cell types.
The mechanism of the toxicity of T-2 toxin is still not clear. T-2 toxin is a
potent inhibitor of protein synthesis (McLaughlin, 1977): It selectively inhibits
peptide bond formation in the late stage of translation initiation and early
elongation (Cundliffe et al., 1974; Smith eta/., 1975). The correlation observed
among T-2 toxin binding to the 605 ribosome, cellular accumulation of the toxin,
and the inhibition of protein synthesis (Middlebrook and Leatherman, 1989a, b)
suggests that cytotoxic action of T-2 toxin may be due to the inhibition of protein
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synthesis. DNA and protein synthesis are suppressed in bone marrow, spleen,
and thymus in mice treated with T-2 toxin (0.75 mg/ kg i.p.) for 8 and 20 hr
(Rosenstein and Lafarge-Frayssinet, 1983), which shows that DNA synthesis
inhibition is also a factor in the toxicity of T-2 toxin.

IMMUNOTOXICOLOGY OF AFLATOXIN B1
AND T-2 TOXIN
Immunosuppressive effects of these mycotoxins have been explored in
many animal species (reviewed by Sharma, 1993). Low-level aflatoxin intake has
the potential to cause serious economic losses to the livestock producer through
reduced productivity or through the impairment of resistance to infectious
agents.

Continuous treatment with AFB1 in the diet (0.5 ppm) for 3 weeks

reduced the acquired resistance to Pasturella multicida strain X-73 in turkey poults
when these animals were immunized against the organism (Pier and Heddleston,
1970). Partially purified aflatoxin-fed pigs (760 mg) for 4 weeks increased the
severity of En;sipelothrix rhusiopathiae infection (Cysewski et al., 1978).
Impairment of phagocytosis was observed in vitro in heterophils when
chickens were fed 0.625-10 ppm aflatoxin and presumed to be due to the
inhibition of production of protein factors by the heterophils (Chang and
Hamilton, 1979). Cell adherence and phagocytic potential of turkey peritoneal
macrophages are decreased when AFB1 (0.01, 0.1, 0.5, 1, and 5 mg) was added in
vitro in the presence of a chicken microsomal mixed function oxidase system.
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These results show that metaboli zed active forms of AFB 1 are responsible for the
action

(Neldon-Ortiz and Qureshi, 1991).

Along with the peritoneal

macrophages, macrophages resident in lungs and in the liver are also affected by
AFB 1. Alveolar and peritoneal macrophages from rats and mice treated with
AFB1 either by aerosol inhalation (3.17 mg/kg) for 60 min or intratracheal
instillation (50-150 mg) showed suppression of phagocytosis (Jakab et al., 1994).
Aflatoxin B1, AFQ1, and M1 (0.1-1 pg/ ml) pretreated rat kupffer cells for 2-24 hr
in vi tro showed inhibition of phagocytosis, intracellular killing of Candida
albicans, and anti-Herpes virus activity. But the AFB, is the more potent among

the metabolites tested, suggesting that AFB, inhibits macrophage functions
(Cusumano el al., 1995).
Male CD-1 mice receiving 0.03-0.7 mg/ kg AFB, orally every other day for
2 weeks showed decrease in T lymphocyte response (Reddy et al., 1987). A
decrease in [3H] thymidine uptake was seen when splenic cells were cultured
with lipopolysaccharide (LPS), phytohemagglutinin (PHA), or poke weed
mitogen (PWM). A decrease in T-dependent antibody production, no effect on
T-independent antibody production, and a dose-related suppression of delayedtype hypersensitivity reaction to keyhole limpet hemocyanin were also observed
in the above studies.

In a similar study (Reddy and Sharma, 1989), where

BALB/ c mice are treated with similar concentration AFB, for 4 weeks,
suppression ofT-helper cells and T-suppressor cells, and NK-cell activity have

been observed.
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These studies clearly suggest that AFB1 affects cell-mediated

immunity even in very low doses.
Aflatoxin B1 is considered a potent mutagen and carcinogen even in the
immune cells; many studies have shown chromosomal aberrations due to AFB 1
exposure of immune cells. Significant aberrations in male Chinese hamster bone
marrow cells are observed within 5 days of administration of AFB1 (0.1-5 mg/ kg)
(Barta et al., 1990). Graded doses of AFB, (1.09-17.4 mg/g embryo), applied on
18-day chick embryo, induced sister chromatid exchanges in the replicating DNA
ofT and B lymphocytes (Potchinsky and Bloom, 1993).
Aflatoxin B, is also known to affect the granulocyte-macrophage
progenitor cell differentiation into formation of granulocyte and macrophage
colonies in vitro.

Bone marrow progenitor cells from AFB, (0.03-07 mg/kg)-

treated mice showed a significant decreased capability to differentiate when
cultured in vitro with the LPS-activated mouse serum (Dugyala et al., 1994).
Similar effects of inhibition of granulopoiesis by AFB, are also shown in rats
(Cukrova et al., 1992a), showing that AFB, may modulate immune functions by
inhibiting the differentiation of progenitor cells into mature progenies.
Very few studies have looked into the alteration of cytokines by AFB1 .
Hatori et al. (1991) observed that C57Blj6 mice treated with 0.03-0.75 mg/kg
AFB1 for 4 weeks showed a decrease in the production of IL-2 by splenocytes
when activated with Con A in vitro. Increased production of IL-1 and IL-2 in
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peritoneal macrophages and splenocytes, respectively, when activated w ith
mitogens in v itro, is observed in rats treated with AFB1 (i.p. 1 mg/kg, single dose)
(Cukrova et al., 1992b).

Tumor necrosis factor production in alveolar

macrophages is decreased in rats treated with AFB1 (50-150 mg) intratracheal
instillation for 3 days (Jakab et al., 1994). In another in vitro study with the bovine
monocytes, AFB1 (10 mg/ml) pretreatment for 24 hr inhibited the IL-Ia mRNA
levels and IL-1 secretion. The authors suggested that the inhibition is general
since the concentration of AFB1 used in this study also inhibited the
constitutively expressed

~-actin

(Kurtz and Czuprynski, 1992).

These results

confirm that the cytokine modulatory role of AFB1 and discrepancies found in
the results in various studies may be due to the utilization of different
experimental designs.
Immunosuppression is the common toxicological manifestation in
humans as well as in various laboratory and food animal species following T-2
toxin exposure. Numerous studies have shown that the thymus is one of the
main target organs of T-2 toxin. Other major organs of toxicity are bone marrow
and spleen. Mice fed with T-2 toxin (20 ppm for 7-41 days) showed atrophy in
thymus, Peyer's patches, and white pulp of spleen and bone marrow cells.
Microscopically, decreased lymphocytes from thymic cortex, hypocellularity in
bone marrow, and splenomegaly show that T-2 toxin is cytotoxic to the immune
cells (Hayes et al., 1980).

Similar results were also observed in thymus and
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spleens of CD-1 mice when treated with T-2 toxin (2.5 mg/ kg for 2-4 weeks)
(Taylor et al., 19S9). However, recent studies with the specific antibodies to the
surface antigens of the different subsets of the lymphocytes showed that T-2
toxin does not show a general cytotoxicity in thymus and spleen but alters
specific subtypes of T and B cells. T-2 toxin (1.75 mg/kg) exposure in mice
showed an increase in CDS- CD4- (immature thymocytes) cells and a decrease in
CDS+ CD4+ cells (Smith et al., 1994), suggesting that T-2 toxin may affect thymic
maturation. Mature T cells were also decreased in spleens in the same study,
suggesting that cell-mediated immune functions are affected. T-2 toxin exposure
(1.2 or 1.5 mg/kg) in mice selectively decreased the prolymphoid cell population
in the fetal liver (Holladay el al., 1993; Holladay et al., 1995).

These studies

provide support to the premise that lymphoid progenitor cells represent highly
sensitive targets of T-2 toxin exposure.
Alteration of cell-mediated immune functions is also observed in T-2
toxin-exposed animals. Male CD-1 mice exposed to T-2 toxin (0.02-5.0 mg/kg)
for 2-4 weeks showed suppression of PHA (T cell mitogen)-stimulation of splenic
lymphocytes.

Delayed type hypersensitivity is decreased even in the lower

doses, suggesting that cell-mediated functions regulated by T cells are largely
affected (Taylor et al., 19S5). Swiss mice treatment with T-2 toxin (i.p. with 0.75
mg/kg, 24 hr for 7 days) was also shown to prolong the period required for
allograft

rejection

and

decrease

the T-dependent antibody

production
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(Rosenstein et al., 1979). However, results from the data of various investigators
should be analyzed cautiously before a conclusion can be reached due to their
use of different experimental designs and treatment schedules.

For example,

mice receiving (i.p.) 1/2 LD 50 on day 0 and 1/4 LD 50 of crude T-2 toxin on day
1 showed a decrease in the PHA and LPS stimulation of splenocytes; and mice
receiving (i. p.) 1/12 LD 50 of crude T-2 toxin for 15 days showed an increase in
the PHA and LPS stimulation of splenocytes (Lafarge-Frayssinet et al., 1979).
These results show that T-2 toxin stimulates the lymphocyte functions in the low
doses and suppresses them in the high doses of treatment.
Similar kinds of discrepancies were also observed in studies involving
cell-mediated inununity to Listeria monocytogeneses

and T-2 toxin exposure.

Preinoculation treatment with a single dose of T-2 toxin (p.o. 4 mg/kg) on day 2
or 4 prior to Listeria challenge significantly enhanced resistance and decreased
mortality due to listeriosis by as much as 50%.

In contrast, resistance was

suppressed and mortality was increased by 50% in mice that were treated with
toxin after the Listeria challenge (Carrier et al., 1987).
T-2 toxin and other trichothecene effects on the macrophages were
studied:

T-2 toxin is cytotoxic to rat alveolar macrophages (AM) in vitro

(Gerberick and Sorenson, 1983). Scanning electron microscope examination of
AM treated with 0.1 mM T-2 toxin demonstrated detachment of pseudopodia,
cellular blebbing, smoothing of membrane processes, and finally cell lysis. T-2
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toxin also .inhibited chemotaxis, chemiluminescence stimulated by bacteria, and
phagocytosis of bacteria in rat leukocytes (Yarom et al., 1984).

T-2 toxin

decreased both MHC class II (Ia) expression and antigen presentation by
epidermal Langerhans cells in mice (Blaylock et al., 1993). In another interesting
study, enriched T lymphocytes from Fusarenon-X (a trichothecene)-treated
mouse spleens showed no functional abnormality as they helped in vitro
production of antibodies by PWM. However, there was a marked inhibition of
antibody formation when the macrophages were added to the T lymphocytes,
clearly showing that T-helper functions are inhibited by the Fusarenon-X-treated
mice macrophages (Masuda et al., 1982). The above discussed studies show that
T-2 toxin and other trichothecenes affect cell-mediated immunity via inhibiting
macrophage structure and functions.
Few studies have been conducted on the alteration of cytokines by T-2
toxin and other closely related trichothecenes. Spleen cells from mice treated for
4 consecutive days with 2 mg/kg T-2 toxin exhibited 4-fold higher levels of IL-2
than control mice but a 50% reduction in in vitro Con A activation (Holt et al.,
1988). A plausible explanation for the reduction of activity may be the lack of
enough effector cells to respond to IL-2. Increased levels of IL-2, IL-4, and IL-5
are also observed in EL-4.IL-2 thymoma cells activated in vitro with
Deoxynivalenol (trichothecene) (Dong et al., 1994).
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Stress response due to the T-2 toxin exposure may also play a role in T-2
immunomodulation. Endotoxemia is caused by the increased levels of endotoxin
in the circulation, which is the result of T-2 toxin exposure in mice (Taylor et al.,
1989).

A parallel increase of corticosterone due to the stimulation of

hypothalamic-pituitary-adrenal axis, and the incidence of endotoxemia 24 hr
after exposure to T-2, suggested that the stress response are due to systemic
endotoxemia (Taylor et al., 1989). In another study, brain biogenic monoamines,
i.e., norephinephrine, serotonin, and 5-hydroxy-3-indoleacetic acid, were
increased in T-2 toxin-exposed rats (Wang et al., 1993a). The neuroendocrine
system is known to affect the immune system (Fuchs and Sanders, 1994).
Immunomodulatory effects of T-2 toxin may also be due to its indirect effects on
the neuroendocrine system.
In summary, both toxins are found to be immunotoxic in various species
by influencing both cell- and humoral-mediated functions affecting mainly Thelper cells and delayed type hypersensitivity functions. Macrophage functions
like adherence, phagocytosis, and chemotaxis are also affected by both toxins.
Many studies have shown the effects of xenobiotics on the immune system, but
the mechanism of immunomodulation is still obscure. The main goal of this
study is to investigate some of the molecular events that are involved in AFB 1
and T-2 toxin-induced immunotoxicity in male CD-1 mice.

The working

hypothesis is that these toxins may produce their immunotoxic effects via
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interference with the synthesis of different cytokines in T lymphocytes and
macrophages, thereby affecting the functions ofT lymphocytes and macro phages
and their interaction with other immune cells. Moreover, there is no single study
demonstrating the inhibition of cytokines at transcriptional or translational levels
by these toxins.

Functions of macrophages are evaluated by their ability to

produce IL-1a, IL-6, and TNF and evaluation of T cell functions by measuring
their ability to produce IL-2, IL-3, and IFNy. Both objectives are approached by
quantifying the specific mRNA for each cytokine, employing Northern blot/ RTPCR techniques, and measuring the individual cytokine protein levels by
sandwich ELISA, after in vitro induction with mitogens in control and toxintreated animals.
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CHAPTER II
ALTERATION OF KEY CYTOKINES PRODUCED BY MITOGENACTIVATED PERITONEAL MACROPHAGES AND
SPLENOCYTES IN AFLATOXIN B1-TREATED
MALE CD-1 MICE

ABSTRACT
Male CD-1 mice were used to test the in vivo effects of aflatoxin B1 (AFB1)
on the genetic expression of key cytokines that modulate activation and
proliferation of splenic lymphocytes (IL-2, IFNy, and IL-3) and macrophages (IL1a, IL-6, and TNF) activated in vitro with LPS and Con A, respectively. Animals
were treated with 0, 0.03, 0.145, or 0.7 mg AFB1/kg body weight orally every
other day for 2 weeks. No significant effects of the toxin on the weights of liver,
kidney, spleen, or thymus, or in red blood cell counts were noted, but white
blood cell counts were significantly elevated at the low (0.03 mg/kg) dose.
Cytokine mRNA levels were measured by RT-PCR or Northern blots and the
secreted protein levels by ELISA. The low dose generally decreased both mRNA
and protein levels of lymphocytic IL-2, IFNy, and IL-3, with IL-2 mRNA
decreasing significantly from control levels

(p~O.OS).

No significant differences

in mRNA or protein levels between treated and untreated controls were found at
the medium or high doses for the three cytokines. AFB1 had a more marked
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effect on macrophage-produced cytokines. While the mRNA levels increased
significantly at the low (IL-la) or medium dose (IL-6 and TNF), their
corresponding protein levels were generally suppressed.

The levels of IL-la

secreted protein were significantly suppressed at all dosages, and those of IL-6
and TNF at high dose. Thus AFB1 treatment appears to preferentially affect
macrophage functions.

These observations and how they relate to possible

mechanisms of AFB1 immunosuppression are discussed.

INTRODUCTION
Aflatoxins are a group of mycotoxins produced by different strains of
fungi such as Aspergillus jlavus and parasiticus. Aflatoxin B1 (AFB1) represents by
far the most toxic of the aflatoxins (Coulombe, 1993). It is a potent carcinogen
that causes hepatoma and other tumors in a variety of animal species (Robens
and Richards, 1992). Hepatic and renal lesions in male broiler chickens, and
hepatic lesions in turkey, ducklings, cattle, pig, sheep, rat, guinea-pig, mouse,
dog, cat, rabbit, monkey, and humans show that AFB 1 affects almost all animal
species (Mollenhauer et al., 1989; Newborn and Buttler, 1969).
Immunotoxic potential of AFB1 is known in many species, including
laboratory and domestic animals (Sharma, 1993).

Decreased lymphocyte

response to different mitogens was observed in several studies. Aflatoxin B1 is
inhibitory to the phytohemeagglutinin (PHA)-stimulated lymphocytes in vitro in
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cattle and humans (Bodine et al., 1984; Savel et al., 1970).

Male CD-1 mice

receiving 0.03-0.7 mg AFB1/kg body weight orally every other day for 2 weeks
showed a decreased T lymphocyte response to lipopolysaccharide (LPS), PHA,
and poke weed mitogen (PWM), and T-dependent antibody production in vitro
(Reddy et al., 1987). Similar treatments in BALB/c mice for 4 weeks resulted in
suppression ofT-helper/ suppressor cells along with the suppression of d elayed
ty pe hypersensitivity and NK cell activity (Reddy and Sharma, 1989). These
results strongly suggest that AFB1 affects cell-mediated immunity.
Apart from the T lymphocytes, macrophages, which are also considered to
be crucial in the immune response, are affected by the AFB1 . Macrophages are
involved in the first line of defense aga inst infectious agents (Skamene and Gros,
1983); they process and present the antigen to the lymphocyte (Unanue, 1984)
and secrete the cy tokines that activate and stimulate proliferation of lymphocy tes
and other effector cells during the immune response (Akira et al., 1990). Reduced
phagocytosis and bactericidal abilities of heterophils from chicken were observed
when fed with dietary aflatoxin (Chang and Hamilton, 1979).

Inhibition of

phagocytosis, intracellular killing of Candida albicans, and intrinsic anti-Herpes
virus activity were observed in rat Kupffer cells when aflatoxins were added in
v itro (Cusumano et al., 1995).

Aerosol and intratrachial instillation of AFB1

inhibits phagocytosis in alveolar and peritoneal macrophages in rats and mice
(Jakab et al., 1994).
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Although there is a large body of data demonstrating that AFB 1 affects
immunity, little is known about the mechanisms of its imrnunotoxicology
(Sharma, 1993). Suppression may occur when a toxin affects the phagocytic
and/ or antigen-processing capacity of the macro phages, the antigen recognition
ability of the lymphocytes, the differentiation and proliferation of T and B
lymphocytes, or the activation of immune effector mechanisms, including the
production and release of cytotoxic lymphocytes, antibodies, and/ or delayed
hypersensitivity mediators.

Since cytokines affect all the above-mentioned

processes directly or indirectly, it is only logical that AFB1 may produce its
immunomodulatory effects through interference with the production of
cytokines in macrophagcs and T lymphocytes.
Few studies have been done involving cytokine production and AFB1
exposure. Hatori et al. (1991) observed a decrease in concanavalin A (Con A)induced IL-2 production in mice treated with AFB1. Respiratory aflatoxicosis
inhibits LPS-induced TNFa production in alveolar macrophages in rats (Jakab et
al., 1994). Interleukin-1 production was decreased in LPS/Listeria monocytogenes-

induced bovine monocytes when pretreated with AFB1 in vitro (Kurtz and
Czuprynski, 1992).

These studies, however, did not explain whether the

analyzed cytokines are inhibited at the transcriptional or translational level by
AFB 1. In the present study, mRNA and protein levels for key cytokines were
determined in peritoneal macrophages (IL-1a, IL-6, and TNF) and splenic
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lymphocytes (IL-2, IFNy, and IL-3) after exposure of CD-1 mice to various doses
of AFB1 in vivo.

The cytokines were selected on the basis of their known

importance in the regulation of acquired immunity (Paul and Sedar, 1994; Akira

et nl., 1990).

MATERIALS AND METHODS

Animals. Male CD-1 mice, 5 weeks old, were obtained from Charles River
Laboratories (Wilmington, MA).

Mice were acclimatized for 7 days in a

temperature-controlled (22 ± 1 °C, 50% relative humidity) and artificially
illuminated room (12 hr light cycle) of an AAALAC-accredited animal care
facility. Pelleted feed (toxin free) and fresh water were provided ad libitum.

Aflatoxin B1 exposure. Aflatoxin B1 was obtained from Sigma Chemical
Co. (St. Louis, MO) and dissolved in a corn oil:ethanol (95:5) vehicle just before
administration. Two sets of mice were separated into four groups (control, low,
medium, and high dose) and were dosed with 0 , 0.03, 0.145, and 0.7 mg
AFB1/kg body weight, respectively. The toxin was administered by oral gavage
every other day for 2 weeks (seven doses). Body weights were recorded daily
throughout the experimental period. Mice were euthanized by carbon dioxide
48 hr after they were given the final dose. From one set of animals, the livers,
thymus, kidneys, and spleens were removed and weighed and the blood was
collected in heparinized tubes for red and white blood cell counts. The spleens
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were removed asceptically and used to isolate splenocytes. The second set of
animals was used for isolation of macro phages by intraperitoneal lavage.

Isolation and activation of splenic lymphocytes.

The asceptically

collected spleens were maintained in cold complete RPM! [RPMI-1640 (Gibco,
Grand Island, NY), 2 mM glutamine, 100 units/ml penicillin, 100 mg/ml
streptomycin, 50 mM 2-mercaptoethanol, 10% heat inactivated fetal calf serum
(FCS) (Hyclone Lab., Logan, UT)]. Monocellular cell suspensions were prepared
using a Stomacher lab blender (STOM 80, Tekmar Co., Cincinnati, OH). Red
blood cells were removed with ACK lysing buffer (0.15M NH4Cl, 1 mM KHC03,
0.1 mM Na2EDTA, pH 7.4). The remaining cells were plated in Falcon 100-mm
plates and incubated at 37°C for 1 hr to allow adherence of macrophages. The
nonadherent cells were collected, counted by automatic blood cell counter
(Coulter Electronic Inc., Hialeah, FL), adjusted to a concentration of 2x106jmJ,
activated with 5 f.lg/ml Concanavalin A (Con A) (Sigma) in complete RPM!, and
replated 15- 20 ml/ plate in 100-mm Falcon culture dishes for 12 or 48 hr.

Isolation and activation of macrophages.

Animals to be used for

isolation of macrophages were injected intraperitoneally with 3 ml 3% Brewers
thioghycolate broth (BIG) (Gibco). On the fourth day post injection, peritoneal
lavage was performed with 5 ml ice-cold complete RPM! + 10 U/ml heparin.
Macrophages were counted in a hemacytometer, adjusted to 106 cells/ml in
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complete RPM! medium, and 5-ml cell suspension were plated in 60-mm dishes.
To activate the cells, lipopolysaccharide (LPS) (Sigma) was added to each plate at
a concentration of 10 f!g/ ml and cultured for 6 or 24 hr.

Total RNA isolation and analysis.

Total RNA was extracted from

lymphocytes after 12 hr activation with Con A and from macrophages after 6 hr
activation with LPS. The lymphocytes were harvested by centrifugation and
total RNA was extracted from the pellet with TRI REAGENT™ LS (Molecular
Research Ctr., Cincinnati, OH) per manufacturer's protocol.

RNA from

macrophages was extracted by removing the medium and applying TRI reagent
to the adherent cells on the plate following manufacturer's instructions. The
purified RNAs were suspended in FORMAzol (Molecular Research) and stored
at-20°C.
Northern analysis of IL-1a, IL-6, and TNF and control P-actin was done
using antisense riboprobes labeled wi th a-32r-UTP or a32P-CTP to a specific
activity -3 x 108 cpm. Antisense transcripts were generated using cloned cDNAs
and the bacteriophage T3 or T7 RNA polymerase (Promega, Madison, WI), per
manufacturer's instructions. Template cDNAs were as follows: for IL-1a, ATCC
clone #63106 in pBluescript SK+, cut with Hind Ill and transcribed with T3; for
IL-6, 800 bp eDNA clone (Pst lends) in pBluescript II KS+, cut with Hind Ill and
transcribed with T7; for TNF, 1230 bp eDNA clone (Eco Rl ends), in pBluescript
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ILKS+, cut wi th Hind III and transcribed with T7. The latter two clones were
obtained from Dr. A. D. Weinberg (University of California, San Diego, CA).
Human P-actin used as control was from ATCC, clone #78554 cut with Hind III,
transcribed with T3. All the clones were sequenced from both ends and found to
conform to respective eDNA sequences in Genbank.
Ten micrograms of total RNA were fractionated through a 1.2% agarose
gel containing 1.1 % formaldehyde. The RNAs were transferred to MAGNA NT
nylon membranes (Micron Separations Inc. Westboro, MA) . The membranes
were stained with 0.02% methylene blue and photographed, and the positions of
18S and 28S ribosomal RNA bands and RNA ladder size markers were noted on
the membrane and later used for sizing and estimation of total RNA loaded per
lane. Prehybridization (approx. 1 hr) and hybridization at 57°C (16 to 24 hr)
were carried out in buffers containing 50 % formamide and the membranes were
washed under high stringency conditions per manufacturer's protocols. The
blots were exposed from 6 hr to overnight to Kodak X-AR film at -70°C with
Dupont Lightning Plus screens. The bands were quantitated by scanning their
densities using ZERO-D scan software program (Stratagene Cloning Systems,
LaJolla, CA). Total RNAs per lane were adjusted using p-actin standards and
the percentage of cytokine RNA in mycotoxin-treated mice were calculated using
untreated group values as 1.
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IL-2, IL-3, and lFNy and P-actin were analyzed by reverse transcriptasepolymerase chain reaction (RT-PCR) using Oligo 4.0-software-selected primer
sets for each sequence as follows:
IL-2 (611 bp):

Sense= 5'-GCGCACCCACTTCAAGCTCC-3'
Antisense= 5'-AGCCCTTGGGGCTT ACAAAA-3'

IL-3 (567 bp):

Sense= 5'-CCCTTGGAGGACCCAGAAC-3';
Antisense= 5'-GCCA TGAGGAACATTCAGAC-3'.

IFNy (510 bp):

Sense= 5'-GTTCTGGGCTTCTCCTCCTG-3';
Antisense= 5'-CGAATCAGCAGCGACTCCTT-3'.

P-actin (265 bp):

Sense= AACACAGTGTTGTCTGGTGG-3';
Antisense= 5'-ACGCAGCTCAGT AACAGTCC-3'

First-strand synthesis was carried out using 1
and 0.5

~g

oligo (dTh2-18 (GibcoBRL), mixed in a

~g

of lymphocyte total RNA

20-~1

total volume reaction

containing 50 mM tris-HCl (pH8.3@RT), 75 mM KC!, 3 mM MgCl2, 10 mM OTT,
0.5 mM each dATP, dCTP, dGTP, and dTTP (Promega), and 200 U SuperScript II
RNase H- RT (GibcoBRL) in a 50-min incubation at 42°C. After heating at 70°C
for 15 min, the mixture was chilled in ice, and 2 units of RNaseH (Boehringer
Mannheim, Indianapolis, IN) were added, followed by a 20-min incubation at 37°
C. Twenty microliters of sterile double-distilled water was then added to the
eDNA and 2

~1

of the diluted samples were used for each polymerase chain
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reaction (PCR). The optimal MgC12 a nd primer concentration in a PCR reac tion
were determined empirically for each cytokine as follows : MgCl2: IL-2 and
actin= 3mM; IL-3 and IFNy= 2mM;
pmol; INFy= 20 pmol;

~-actin=

~-

Primer concentration: IL-2 and IL-3= 30

10 pmol.

Amplification was done in a

TempCyclerll thermocycler (Coy Lab. Inc., Ann Arbor, MI) as follows: hot start
a t 95°C for 30 sec, followed by 25 cycles a t 94°C, 30 sec; ssoc, 30 sec; 72°C, 1 min.
The PCR products were run on 2% agarose gels, visualized by ethidium
bromide, and quantitated by scanning photograph negatives as described for
Northern blots.

Cytokine quantitation. Supernatants from macrophage cultures activated
for 24 hr were used to quantitate IL-la, IL-6, and TNF.

Supernatants from

splenocy te cultures activated for 48 hr were used to quantitate IL-2, IL-3, and
IFN-y. All supernatants were frozen and maintained at -70°C until assayed. All
cytokines were quantitated by ELISA, using kits from either Genzyme
Diagnostics, Cambridge MA (IL-la, IL-2, IL-6, TNF, and IFN-y) or Endogen, Inc.,
Cambridge, MA (IL-3) per manufacturer's instructions.

Statistical methods. Data from these studies were analyzed by one-way
analysis of variance (ANOV A) followed by the Fisher PLSD.

Statistical

calculations utilized Stat view TM SE +Graphics software from Abacus Concepts,
Inc.
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RESULTS
Organ weight determination and cell counts revealed no effects of AFB1
treatment on liver, kidney, spleen, or thymus weight or on red blood cell counts.
The lowest dose (0.03 mg/kg body weight), however, caused a significant
increase in the number of white blood cells when compared to the control
groups. The medium dose, 0.145 mg/kg, also caused an increase in the number
of white blood cells, but the increase was not significant. No marked changes in
white blood cells were seen at the highest dose (0.7 mg/kg) (Table Il-l).
The effect of AFB1 on IL-2, IL-3, and lFNy gene expression was determined
by RT-PCR analysis of total mRNA extracted from splenic lymphocytes of
treated and untreated animals, after 12 hr activation with ConA in vitro (Figs. ll1-3). AFB 1 administered at the low dose of 0.03 mg AFB1 per kg body weight
decreased the level of all three mRNAs, with IL-2 registering a significant
difference (p_:::O.OS) from the control groups (Fig. Il-l). No significant difference
in IL-2, lL-3, and IFNy mRNA was found between control groups and animals
treated at the medium (0.145 mg AFB1/kg body weight) or high (0.7 mg
AFB1/kg body weight) dose levels. The levels of P-actin mRNA were similar in
all the groups.
Interleukin-la, IL-6, and TNF gene expression in thioglycolate-brothstimulated, AFB1-treated and control animals was determined by Northern blot
analysis (Figs. II-4-6). Total mRNA was extracted from macrophages after 6 hr
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TABLE 11-1
Selected organ weights and blood cell counts of CD-1 mice exposed to AFB1
for two weeks a
Organs (g/100 g body weight)
_____________________________ RBC

WBC

AFB1
(mg/ kg) Liver

Kidney

Spleen

Thymus

(x10•j mm3) (x10•j mm3)

0

6.05 ± 0.23

1.69 ± 0.11

0.28 ± 0.02

0.28 ± 0.03

8.26 ± 0.43

0.03

6.22 ± 0.40 1.62 ± 0.05

0.145

6.15 ± 0.28 1.73 ± 0.12 0.34 ± 0.03

0.34 ± 0.02

7.98 ± 0.09 10.63 ± 0.49

0.7

5.73 ± 0.15 1.73 ± 0.06

0.34 ± 0.03

7.94 ± 0.50

0.28 ± 0.02 0.28 ± 0.02

0.27 ± 0.03

7.94± 0.12

a Values are given as mean± S.E., n=S.
*Significantly different from the control valve (p < 0.05).

8.20 ± 0.53
12.36 ± 1.50*

9.32 ± 1.25
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FIG. Il-l. Effect of AFB 1 on the Con A-induced IL-2 expression. Total RNA
(1 ~)of the Con A-activated (5 ~/2x1()6 cells for 12 hr) splenocytes from
control and AFB 1-treated mice were used to make eDNA and amplified by
RT-PCR using murine IL-2 and murine j>-actin primers(A). Band densities
from five different animals were measured from the negatives of the
ethidium bromide stained 2% agarose gels by Zero D-scan. Values of the
total PCR product per lane were measured and equalized using j>-actin
standards, and the total IL-2 PCR product in the treated groups was calculated as percent of control values(B). Data points were mean± S. E. (n=5).
(*) Differences significant at p ~ 0.05 level.
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FIG. 11-2. Effect of AFB 1 on the Con A-induced IL-3 expression. Total RNA
(1~-tg) of the Con A-activated (5~-tg/2xHJ6 cells for 12 hr) splenocytes from
control and AFB 1-treated mice were used to make eDNA and amplified by
RT-PCR using murine IL-3 and murine [3-actin primers (A). Band densities
from five different animals were measured from the negatives of the
ethidium bromide stained 2% agarose gels by Zero D-scan. Values of the
total PCR product per lane were measured and equalized using [3-actm
standards, and the total IL-3 PCR product in the treated groups was
calculated as percent of control values (B). Data points were
mean± S. E. (n=5).
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FIG. II-3. Effect of AFB 1 on the Con A-induced IFNyexpression. Total RNA
(1 J.Jg) of the Con A-activated (5 J.Jg/2xl(J6 cells for 12 hr) splenocytes from
control and AFB 1-treated mice were used to make eDNA and amplified by
RT-PCR using murine IFNyand murine j3-actin primers(A). Band densities
from five different animals were measured from the negatives of the
ethidiurn bromide stained 2% agarose gels by Zero D-scan. Values of the
total PCR product per lane were measured and equalized using j3-actin
standards, and the total IFNyPCR product in the treated groups was
calculated as percent of control values(B). Data points were mean ±S. E.
(n=5).
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FIG. 11-4. Effect of AFB 1 on the LPS -induced IL-1a expression. Total RNA
(10 j.!g) of the LPS- activated (10 !lg/lx106 cells for 6 hr) peritoneal
macrophages from control and AFB 1- treated mice were analyzed by
Northern blot using murine IL-1a and human ~actin 32 P-labeled
riboprobes {A). Band densities from three different animals were measured
by Zero D-scan. Values of the total RNA per lane were measured and·
equalized using ~actin standards, and the total IL-1amRNA in the treated
groups was calculated as percent of control values(B). Data points were
mean± S. E. (n=3). (*) Differences significant at p $. 0.05 level.

61

A.

. . TNF

. . !3-actin

0

0.7

0.145

0.03

AFB, (mg/kg)

0.7

AFB, (mg/kg)

300

B.

'z""

E--

250

0

"'
OJ
:>
.!!:i

<
~

200
150

E 100

0....

-;::
0

u

?.

50
0

0

0.03

0.145

FIG. 11-5. Effect of AFB1 on the LPS -induced TNF expression. Total RNA
(10 ~-~g) of the LPS- activated (10 ~g/lx106 cells for 6 hr) peritoneal
macrophages from control and AFB 1- treated mice were analyzed by
Northern blot using murine TNF and human ~-actin 32 P-labeled
riboprobes (A). Band densities from three different animals were measured
by Zero D-scan. Values of the total RNA per lane were measured and·
equalized using ~-actin standards, and the total TNF mRNA in the
treated groups was calculated as percent of control values (B).
Data points were mean± S. E. (n=3). (*) Differences significant at
p .::;. 0.05 level.
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FIG. II-6. Effect of AFB 1 on the LPS -induced IL-6 expression. Total RNA
(10 J.lg) of the LPS- activated (10 !J.g/lx106 cells for 6 hr) peritoneal
macrophages from control and AFB 1- treated mice were analyzed by
Northern blot using murine IL-6 and human ~-actin 32 P-labeled
riboprobes (A). Band densities from three different animals were measured
by Zero D-scan. Values of the total RNA per lane were measured and·
equalized using ~-actin standards, and the total IL-6 mRNA in the treated
groups was calculated as percent of control values (B). Data points were
mean± S. E. (n=3). (*)Differences significant at p .$. 0.05 level.
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LPS induction in vitro. The results show a significant increase in IL-la mRNA in
anima ls treated with AFB1 at low dose (Fig. Il-4). The medium dose level groups
show a significant increase in both TNF (Fig. II-5) and IL-6 (Fig. Il-6) mRNA
levels, while the high dose groups show a significant suppression of both IL-la
and TNF (Figs. II-4, 5).

No marked difference in the levels of P-actin was

observed in any of the groups.
The effect of AFB1 on the cytokine protein products was analyzed by
ELISA.

The supernatants of splenocyte cultures from treated and untreated

animals were collected after 48 hr activation with Con A and used to quantitate
IL-2, IL-3, and IFNy. Figs. Il-7-9 show that for all three cytokines, AFB1 treatment
at all dose levels had no significant effect on the amount of protein secreted into
the supernatant.
The pattern of protein production follows closely that observed for mRN A
levels, i.e., a slight decrease of protein is observed at low dosage in all three
cytokines, followed by a recovery to normal levels at medium and high dose
levels. The only exception is IL-2, where a decrease in mRNA at low dosage is
significant while the protein levels, although also suppressed, do not appear to
be significantly different from the controls.
Similar ELISA analysis was performed for IL-la, IL-6, and TNF using the
supernatant from macrophage cultures after LPS induction for 24 hr in vitro
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Fig. II-7. Effect of AFB 1 on IL-2 production. Splenocytes
(2xl()6 /rnl) from control and AFB 1-treated mice were activated
with 5 f.lg/ml Con A for 48 hrs. lnterleukin-2 in culture supernatants
was detected by ELISA. Data were mean ±S. E. (n=4).

65

0.8
0.7
0.6

E

0.5

-......

bO

5

0.4

<'}

~

0.3
0.2
0.1
0.0
0

0.03

0.145

0.7

AFB 1 (mg/ kg body weight)

Fig. II-8. Effect of AFB 1 on IL-3 production. Splenocytes
(2x106 /ml) from control and AFB 1-treated mice were activated
with 5~-~g/ml Con A for 48 hrs. Interleukin-3 in culture supernatants
was detected by ELISA. Data were mean± 5. E. (n=4).
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Fig. II-9. Effect of AFB 1 on IFNyproduction. Splenocytes
(2x106 /ml) from control and AFB1-treated mice were activated
with 5 J.tg/ml Con A for 48 hrs. Interferon yin culture supernatants
was detected by ELISA. Data were mean ±S. E. (n=4).
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(Figs. 11-10-12). A dramatic decrease in IL-1a was observed after treatment at all
dose levels of AFB1, and the suppression was significant when compared to the
control groups (p_:::O.OS) (Fig. II-10). A significant suppression of TNF and IL-6
was also observed, but only at the highest dose of AFB1 (Figs. II-11, 12).
In contrast to IL-2, IFNy, and IL-3, where the levels of mRNA and protein
seem to be closely correlated after all levels of AFB1 treatment, IL-1a, IL-6, and
TNF mRNA and protein levels do not appear to be closely correlated. Messenger
RNA appears to be superinduced at the low (IL-1a) or medium (IL-6 and TNF)
dosage of AFB1, but this superinduction does not translate into increased
amounts of cytokines secreted into the medium. In fact, there seems to be a
generalized suppression of cytokine secretion at all treatment levels, with the
effect being most significant for IL-1a.

Thus it appears that AFB1 treatment

preferentially affects macrophage functions, and, in particular, it decouples the
close correlation usually observed between transcriptional and translational
controls of IL-1a, IL-6 and TNF production by these cells.

DISCUSSION
This study used male CD-1 mice to describe the in vivo effects of AFB1 on
the genetic expression and production of several cytokines that modulate
activation and proliferation of splenic lymphocytes and macrophages.

Its

under! ying assumptions are that AFB1 exerts its irnrnunotoxic effects by
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Fig. II-10. Effect of AFB 1 on IL-1a production. BIG-stimulated
peritoneal macrophages (lx106 /ml) from control and AFB 1-treated
mice were activated with 10 ~/ml LPS for 24 hrs. Interleukin-1a
in culture supernatant was detected by ELISA. Data were mean ± S. E.
(n=3). (*) Significant difference at 0.05 level between treatment and
control groups.
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Fig. II-11. Effect of AFB 1 on TNF production. BTG-stimulated
peritoneal macrophages (1x106 /ml) from control and AFB 1-treated
mice were activated with 10 J.!g/ml LPS for 24 hrs. Tumor necrosis
factor in culture supernatant was detected by ELISA. Data were mean
± S. E .(n=3). (*)Significant difference at 0.05 level between treatment
and control groups.
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Fig. II-12. Effect of AFB 1 on IL-6 production. BIG-stimulated
peritoneal macrophages (1x106 /ml) from control and AFB 1-treated
mice were activated with 10 J.Jg/ml LPS for 24 hrs. Interleukin-6 in
culture supernatant was detected by ELISA. Data were mean± S. E.
(n=3). (*)Significant difference at 0.05 level between treatment and
control groups.
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alterating cytokine production in these cells and that analysis of the nature of
those alterations will shed light on the molecular mechanisms involved in the
toxin-induced immunosuppression.
The doses and duration of the AFB, exposure used in this study did not
seem to be toxic as they did not affect the liver, kidney, thymus and spleen
weights as described in previous reports (Reddy et al. , 1987; Reddy and Sharma,
1989; Dugyala et al., 1994). There was no effect on the erythrocyte counts but
there was a significant elevation in the leukocyte counts at low dose (0.03 mg
AFB,/kg body weight), which was also observed in an earlier study (Dugyala et
al., 1994); this suggests that the doses of AFB, used in this study also have minor

sub-clinical effects.
The levels of IL-2, IL-3, and IFNy protein secreted in the medium by Con
A-treated lymphocytes corresponded in general to their respective mRNA levels
but did not differ significantly from untreated control values, with the exception
of IL-2 mRNA, which is suppressed significantly in the low-dose groups.
Although not statistically significant, there was a general reduction of all three
cytokine mRNA and protein levels at low dose. This is interesting in light of the
fact that aflatoxin is known to affect cell-mediated immunity (i.e., suppression of
delayed-type hypersensitivity, natural killer activity, and T-helper cell functions)
in mice at low and repeated doses (Reddy et al., 1987; Reddy and Sharma, 1989).
Hatori et al. (1991) observed that C57B1/6 mice treated with similar doses used
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in this study, showed a decrease in IL-2 production in the highest-dose-trea ted
group and no effect in other AFB1-treated groups. The discrepancy may be due
to their use of a 4-week exposure instead of 2 weeks used in the present study.
A number of factors may have caused the observed reduction in IL-2 and
IFNy mRNA and protein levels at low doses of AFB1.

CD4+ T cells are

subdivided into two distinct subsets based on the pattern of lymphocyte
secretion; TH1 cells produce IL-2 and IFNy (and other cytokines) but not IL-4, IL5, IL-6, and IL-10, and are involved in cell-mediated immune responses. TH2
cells produce IL-4, IL-5, IL-6, and IL-10, but not IL-2 and IFNy, and are involved
in antibody-mediated immune responses (Mosmann and Coffman, 1989). IL-3 is
produced by both types of cells. Emergence of the dominant subset ofT-helper
cells is dependent on the induction of specific cytokine profiles during the
immune response.

For example, macrophages, especially when infected by

intracellular bacteria, are potent inducers of IL-12, directing the T-helper cell
development toward TH1 responses (Hsieh el al., 1993).

In the absence of a

source of high concentration of IL-12, production of IL-4 by subsets of CD4+ T
cells may prevent TH1 cell development and the production of cytokines (Gollob
and Coffman, 1994; Yoshimato and Paul, 1994). Interleukin 10 produced by the
TH2 cells, acting in conjunction with antigen presenting cells, also inhibits the TH1
production of IFNy and IL-2 (Fiorentino et al., 1989). Cholera toxin, cyclosporin
A, 8-Br-cAMP, and prostaglandin E2 are also known to preferentially inhibit TH1
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cell-produced cytokines through their unique T cell receptor-associated signal

transduction pathways (Gajewski et al., 1990; Munoz et nl., 1990; Betz and Fox,
Activation of RNA and protein synthesis in mouse splenocytes was

1991).

observed in the low dose exposure to AFB1 in BALB/c mice for 4 weeks (Reddy
and Sharma, 1989). Activation of protein synthesis was also detected in CD-1
mice exposed for 2 weeks (Reddy et al., 1987). Therefore, the low-dose inhibition
of IL-2 and IFNy observed in this study may be due to activation of any of the
above-discussed factors, which results in the suppression of THl cytokine
products.

Further studies are needed to explore these mechanisms of

immunomodulation and the nature of TH1/TH2 cell subsets in CD4+ T cell
population during AFB, exposure.
The levels of IL-la, IL-6, and TNF protein secreted by LPS-stimulated
macrophages varied significantly from the controls; IL-6 and TNF levels were
reduced significantly at high dosages, and IL-1a at all dosages administered.
The fact that the mRNA levels did not correspond to those of the proteins at the
low and medium dosages indicates a breakdown of the usual transcriptional
regulation of these cytokines. In the high-dose-treated animals, both mRNA and
protein decreased, significantly so for IL-la and TNF. The results show that
AFB1 suppresses IL-la gene expression and regulation transcriptionally in high
dose groups and more strongly at the post-transcriptional level in all dose
groups.

Interleukin-la and IL-lP do not possess a typical NH2-terminal
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hyd rophobic secretory signal sequence responsible for translocation of the
proteins directly into the endoplasmic reticulum via the classic exocytic secretory
pathway (Giri et al., 1985).

As a consequence, the newly synthesized IL-1a

precursor protein is localized in the cytoplasm where it is cleaved by the
proteolytic enzyme calpain; subsequently it undergoes a conformational change
that exposes the required secretory signal to be secreted out upon an activation
signal (Carruth et al., 1991; Hazuda et al., 1991; Siders et al., 1993). Aflatoxin B1
may affect any of the above discussed processes; it may inhibit the proteolytic
enzyme or the subsequent events leading to the secretion of IL-1a. Pentamidine,
an aromatic diamidine currently used to treat Pneumocystis carinii, specifically
inhibits the cleavage of pro-IL-1a and its secretion (Rosenthal et al., 1991).
Even though protein levels of IL-6 and TNF are not suppressed
significantly, the fact that they do not correlate with the increased mRNA levels
in the medium dose groups and the decreased protein levels in the high dose
group shows that AFB, may affect some of the general translational machinery of
the cell or its secretory pathway. Direct damage to the endoplasmic reticulum
membranes, interference with the ribosome binding sites, interference with the
ribosomal cycle, and inhibition of the release of newly synthesized proteins that
may affect the ER-mediated protein synthesis are all alterations that have been
observed during AFB1 exposure (Terao and Ueno, 1978; Viviers and Schabort,
1985).
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The significant changes observed in mRNA and protein levels for all three
cytokines may be due to the differential regulation of factors responsible for
transcription or mRNA stability by AFB1.

Aflatoxin B1 has the property of

binding to the macromolecules via the formation of AFB1-8,9 epoxide and, to a
lesser extent, its hydration product, the dihydrodiol form.

The epoxide

specifically makes an electrophilic attack on the N7 position of guanine in DNA
and RNA (Croy eta/., 1978; Essigman eta/. , 1980; Croy and Wogan, 1981a, b;
Benasutti et al., 1988), while the dihydrodiol forms a schiff base w ith amino
grou ps of the bases (Hsieh, 1987). The inhibitory effects of AFB1 may be on the
DNA template activity and RNA polymerase II, an enzyme largely responsible
for mRNA synthesis (Yu, 1977). AFB1 also interferes with RNA chain elongation
(Yu, 1981).
The elements in the 5' regulatory regions including glucocorticoid
regulatory elements, NFKB, AP-1 binding sites, and NF-IL-6 have been shown to
be involved in the transcriptional regulation, whereas AUUUA sequences in the
3'-untranslated region are the sites of cytosolic protein associations that
stabilize/ degrade

the cytokine

mRNA and

regulate

the

stability and

translational efficiency (Caput eta/., 1986; Shaw and Karmen, 1986; Brown and
Beutler, 1990; Natsuka eta/., 1992; Henics eta/., 1994). Protein kinase C enhances
the removal of poly (A) from TNF mRNA, thereby faci litating the early mRNA
degradation (Lieberman et a/., 1992).

Phorbol esters and calcium ionophores
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ha ve been. shown to stabilize IL-2 mR NA via protein kinase C (PKC)-dependent

phosphorylation as it is blocked by the inhibitors of PKC, such as staurosporine
and K252a (Ohmura and Onoue, 1990). Moreover, the addition of an inhibitor of
serine/ threonine protein phosphatases (i.e., okadiac acid) resulted in increased
instability of IL-2 mRNA, which further supports that protein phosphorylation
plays a n important role in the mRNA stability (Ohmura and Onoue, 1990). All
these events require de novo protein synthesis, which can be altered by the AFB1.
Immunosuppressant drugs such as FK506 and rapamycin inhibit mRNA stability
of cy tokines by a mechanism involving PKC-regulated AUUUA-specific binding
proteins (Tocci et al., 1989; Hanke et al., 1992). There is evidence that AFB1 binds
to the cytoplasmic molecules destined for the nucleus (Ch'ih ami Dev lin, 1984;
Ch'ih et al., 1993). Moreover, AFB1 preferentially binds to the physiologically
active regions of the nucleolar chromatin of rat liver cells (Yu, 1983). A decrease
of mRNA induction of IL-1a and TNF and no effect on mRNA of IL-6 may be
due to their differences in the time of expression and regulation (Akira et al.,
1990). Whether any of these processes are affected by AFB1 in the immune cells
needs to be further investigated.
Among the cytokines analyzed, IL-1a seems to be more sensitive to AFB 1
at all dose levels tested than IL-6 and TNF; this shows that the mechanism of
action of AFB, is specific.

Interleukin 1a is the most abundantly produced

cytokine in mice; its level is above that of IL-1P. It plays a very important role in
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immune regulation; together with IL-6 and TNF, it plays a pivotal role in cellmediated immunity, as well as in the regulation of inflammatio n and
hema topoiesis (Rosenthal et al., 1991; Dinarello, 1992). Interleukin-1 amplifies T
cell activation by inducing IL-2 and IL-2R gene expression, particularly in
conjunction with antigens and mitogens (Dinarello, 1992). The activation of
mature T cells by IL-l is dramatically increased in combination with IL-6, which
shows that the two cytokines act synergistically (Dinarello, 1992).

Tumor

necrosis factor also plays a role in the development of cell-mediated immunity by
inducing the cytotoxic T lymphocytes and generating IL-2 and IL-12 (Fiers, 1991).
Based on the present investigation, AFB1 seems to affect cell-mediated immunity
mainly by affecting the macrophage-producing cytokines. The results would be
an inhibition of the signals activating THl cells to respond to foreign antigen. It
does not seem to have much effect on THl cytokine production in spite of the
slight decrease in production of Con A-induced cytokines by splenocytes in the
low-dose-treated groups.
The observations strengthen the conclusion that AFB, main effects are on
the macrophages.

Various studies have shown that aflatoxin inhibits

macrophage functions such as phagocytic, chemotactic, microbicidal, and
adherence activity (Chang and Hamilton, 1979; Neldon-Ortiz and Qureshi, 1991;
Jakab et al., 1994; Cusumano et al., 1995).

These impaired functions of

macrophages will definitely affect the first line of defense against infectious
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diseases (Skamene and Gros, 1983). More importantly, macrophages take up
and process foreign substances and present the derived antigens to lymphocytes,
as well as secrete cytokines, which are important for the development of
acquired immunity (Unanue, 1984).

By adding the present results to other

studies, the conclusion that AFB1 mainly affects cell-mediated immunity via
inhibition of macrophage functions is warranted.
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CHAPTER III
ALTERATION OF KEY CYTOKINES PRODUCED BY MITOGENACTIVATED PERITONEAL MACROPHAGES AND
SPLENOCYTES IN T-2 TOXIN-TREATED
MALE CD-1 MICE

ABSTRACT
Male CD-1 mice were used to study the effect of in vivo exposure to T-2
toxin on the alteration of IL-1a, TNF, and IL-6 cytokines in LPS-stimulated
peritoneal macrophages, and IL-2, IL-3, and IFNy cytokines in Con A-stimulated
splenocytes. Mice received 0, 0.1, 0.5, and 2.5 mg T-2 toxin/kg body weight
orally for 2 weeks on alternate days. Northern blot analysis of IL-1a, TNF, and
IL-6 mRNA from activated peritoneal macrophages showed no significant
differences between control and treated groups.

ELISA measurements of

secreted protein demonstrated suppression of these cytokines in all groups when
compared to the controls. Thus T-2 toxin appears to affect the translational or
post-translational regulation of cytokines from peritoneal macrophages. IL-2, IL3, and IFNy mRNA levels from Con A-activated splenocytes were higher in all
treated groups; the increases were significant for IL-2 and IFNy in the groups
receiving low (0.1 mg/ kg) and high (2.5 mg/ kg) doses of T-2 toxin, and for IL-3
in the group receiving a medium (0.5 mg/kg) dose of this toxin

(p~

0.05). The
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data indicate that T-2 toxin at low or med ium doses induces transcription or
increases mRNA stability of IL-2, IF Ny, and IL-3. The protein levels of all three
cy tokines were also increased significantly; for IL-2 and IFNy at the low dosage,
and for IL-3 at low and medium dosages, indicating that T-2 toxin also increases
translational/ post-translational efficiency of all three cytokines. The poss ible
mechanisms involved in the immunosuppressive effects of T-2 tox in are
discussed relative to these findings.

INTRODUCTION
T-2 toxin [12, 13-epoxytrichothec-9-ene-3, 4, 8, 15-tetrol 4, 15-diacetoxy-8(3-methyl-butanoate)] is one of the many trichothecene mycotoxins produced by
several genera of fungi, particularly the Fusarium species.
human

and

animal

stachybotriotoxicosis,

diseases
affecting

such
the

as

alimentary

mucosa

and

the

It causes severe

toxic

aleukia

immune

and

system.

Leukopenia, anemia, and bone marrow aplasia are the most common
pathological symptoms of these diseases (Sharma and Kim, 1991). T-2 toxin has
systemic effects on nearly every major organ system, including cardiovascular,
central nervous system, bone marrow, liver, and the gastrointestinal tract in
animals and humans (Ueno et al., 1973; Weaver et al., 1978; Hayes and Schiefer,
1980; Hayes et al., 1980; Lusky and Mor, 1981; Ueno, 1983; Joffe, 1986; Pang et al.,
1987; Dugyala et al., 1991).
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The immunotoxic potential of T-2 toxin in different animals has been
reviewed and found to selectively affect various subpopulations of immune cells
such as lymphocytes and macrophages (Sharma, 1993). Decrease of cytotoxicity,
phagocytosis and chemotaxis were observed in human polymorphonuclear cells
and rat alveolar macrophages when treated with T-2 toxin (Gerberick and
Sorenson, 1983; Yarom et al., 1984). CD-1 mice exposed for 2 or 4 weeks to T-2
toxin (0.02-5.0 mg/ kg body weight) showed a suppression of thymus-derived T
cell mediated function and delayed-type hypersensitiv ity but normal T cell
dependent antibody production and antibody-producing cells (Taylor et al.,
1985). These data indicate that T-2 toxin has a specific immunomodulatory
effec t in mice. Some of the imrnunomodulatory effects of T-2 toxin are indirec t,
acting via the hypothalamic-pituitary-adrenal (HPA) axis in mice (Taylor et al.,
1989; Taylor et al., 1991). T-2 toxin administred to pregnent mice has been found
to specifically decrease prolymphoid cell populations in fetal thymus, liver and
bone marrow cells (Holladay et al., 1993; Holladay et al., 1995). T-2 toxin has also
been reported to lower lymphoid DNA and protein synthesis (Rosenstein and
Lafarge-Frayssinet, 1983), and antibody synthesis (Rosenstein et al., 1979).

In

experimental models, T-2 toxin has also been reported to cause decreased
resistance to mycobacterial infection (Kanai and Kondo, 1984), increased
mortality after challenge with Salmonella species (Tai and Pestka, 1990), increased
susce ptibility to herpes simplex virus (Friend et al., 1983), and increased
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mortality in listeriosis (Carrier et al., 1987). While it is known that T-2 toxin
inhibits cellular protein, DNA, and RNA synthesis (Carrier and Ziprin, 1986;
Mann et al., 1983; Lafarge-Frayssinet et al., 1981; Gyongyossy-Issa and
Kachatourians, 1985; Gyongyossy-Issa et al., 1986; Deloach et al., 1989), little is
known about the mechanism involved in the immunomodulation.
Understanding the mechanism of immunosuppression of T-2 toxin is very
difficult due to its complex effects on the immune response in vivo, which are still
obscure. Suppression may occur when a toxin affects the phagocytic and/or
antigen-processing capacity of the macrophages, the antigen recognition ability
of the lymphocytes, the differentiation and proliferation ofT and B lymphocytes,
or the activation of immune effector mechanisms, including the production and
release of cytotoxic lymphocytes, antibodies, and/or delayed hypersensitivity
mediators. Since cytokines affect all the above-mentioned processes directly or
indirectly, it is only logical that T-2 toxin may produce its immunomodulatory
effects through interference with the production of cytokines in macrophages
and T lymphocytes. Few studies have investigated cytokine (IL-2) production
and T-2 toxin exposure (Holt et al., 1988b). In the present study, mRNA and
protein levels for several key cytokines were determined in macrophages (IL-la,
lL-6, and TNF) and splenic lymphocytes (IL-2, IFNy, and IL-3) after exposure of
CD-1 mice to various doses of T-2 toxin in vivo. The cytokines were selected on

91
the basis of their known importance in the regulation of acquired immunity
(Akira et nl., 1990; Paul and Sedar, 1994).

MATERIALS AND METHODS

Animals. Male CD-1 mice, 5 weeks old, were obtained from Charles River
Laboratories (Wilmington, MA).

Mice were acclimatized for 7 days in a

temperature-controlled (22 ± 1 °C, 50% relative humidity) and artificially
illuminated room (12 hr light cycle) of an AAALAC-accredited animal care
facility. Pelleted feed (toxin free) and fresh water were provided ad libitum.

T-2 toxin exposure. T-2 toxin was obtained from Sigma Chemical Co. (St.
Louis, MO) and dissolved in a corn oil:ethanol (95:5) vehicle just before
administration. Two sets of mice were separated into four groups (control, low,
medium, and high dose) and were dosed with 0, 0.1, 0.5, or 2.5 mg T-2 toxin/ kg
body weight, respectively. T-2 toxin was administered by oral gavage every
other day for 2 weeks (seven doses).

Body weights were recorded daily

throughout the experimental period. Mice were euthanized by carbon dioxide
after 48 hr of the final dose. From one set of animals, the livers, thymus, kidneys,
and spleens were removed and weighed and the blood was collected in
heparinized tubes for red and white blood cell counts.

The spleens were

removed asceptically and used as a source of splenocytes. Macrophages were
isolated from the second set of animals by intraperitoneal lavage.
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Isolation and activation of splenic lymphocytes.

The asceptically

collected spleens were maintained in cold complete RPM! [RPMI-1640 (Gibco,
Grand Island, NY), 2 mM glutamine, 100 units/ml penicillin, 100 mg/ ml
streptomycin, 50 mM 2-mercaptoethanol, 10% heat inactivated fetal calf serum
(FCS) (Hyclone Lab., Logan, UT)] . Monocellular cell suspensions were prepared
using a Stomacher lab blender (STOM 80, Tekmar Co., Cincinnati, OH) . Red
blood cells were removed with ACK lysing buffer (0.15 M NH4Cl, 1 mM
KHC03, 0.1 mM Na2EDT A, pH 7.4). The remaining cells were plated in Falcon
100 mm plates and incubated at 37°C for 1 hr to allow adherence of
macro phages. The nonadherent cells were collected, counted by automatic blood
cell counter (Coulter Electronic Inc., Hialeah, FL), adjusted to a concentration of 2
x 106/ ml, activated with 5 mg/ ml concanavalin A (Con A) (Sigma) in complete
RPM!, and replated 15- 20 ml/ plate in 100-mm Falcon culture dishes for 12 or 48
hr.

Isolation and activation of macrophages.

For macrophages, animals

were injected intraperitoneally with 3 ml of 3% Brewers thioglycolate broth
(BTG) (Gibco).

On the fourth day post injection, peritoneal lavage was

performed with 5 ml ice-cold complete RPM!+ 10 U/ml heparin. Macrophages
were counted in a hemocytometer, adjusted to 106 cells/ml in complete RPM!
medium, and 5 ml of the cell suspension were plated in 60-mm dishes.

To
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acti va te the cells, lipopolysaccharide (LPS) (Sigma) was added to each plate at a

concentration of 10 mg/ ml and cultured for 6 or 24 hr.
Total RNA isolation and analysis.

Total RNA was extracted from

lymphocytes after 12 hr activation with Con A and from macrophages after 6 hr
activation with LPS. The lymphocytes were harvested by centrifugation and
total RNA was extracted from the pellet with TRl REAGENT™ LS (Molecular
Resea rch Ctr., Cincinnati, OH) per manufacturer's protocol.

RNA from

macrophages was extracted by removing the medium and applying TRI reagent
LS to the adherent cells on the plate following manufacturer's instructions. The
purified RN As were suspended in FORMAzol (Molecular Research) and stored

Northern analysis of IL-Ia, IL-6, and TNF and control (3-actin was done
using antisense riboprobes labeled with 32P-UTP or 32r-CTP to a specific activity
?,3 x 108 cpm. Antisense transcripts were generated using cloned cDNAs and the
bacteriophage T3 or T7 RNA polymerase (Promega, Madison, WI), per
manufacturer's instructions. Template cDNAs were as follows: for IL-1, ATCC
clone #63106 in pBluescript SK+, cut with Hind III, transcribed with T3; for IL-6,
800 bp eDNA clone (Pst I ends) in pBluescript II KS+, cut with Hind III,
transcribed with T7; for TNF, 1230 bp eDNA clone (Eco Rl ends), cut with Hind
Ill, transcribed with T7. The latter two clones were obtained from Dr. A. D.
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Weinberg (Univeristy of California, San Diego, CA).

Human ~-actin used as

control was from ATCC, clone #78554 cu t with Hind Ill, transcribed with T3. All
the clones were sequenced from both ends and found to conform to respective
eDNA sequences in Genbank.
Ten micrograms of total RNA were fractionated through a 1.2% agarose
gel containing 1.1 % formaldehyde. The RNAs were transferred to MAGNA NT
ny lon membranes (Micron Separations Inc. Westboro, MA). The membranes
were stained with 0.02% methylene blue and photographed, and the positions of
18S and 285 ribosomal RNA bands and RNA ladder size markers was noted on
the membrane and later used for sizing and estimation of total RNA loaded per
lane.

Prehybridization (approx. 1 hr) and hybridization at 57°C (16 to 24 hr)

were carried out in buffers containing 50% formamide and the membranes were
washed under high stringency conditions per manufacturer's protocols.

The

blots were exposed for 6 hr to overnight to Kodak X-AR film a t -70°C with
Dupont Lightning Plus screens. The bands were quantitated by scanning their
densities using ZERO-D scan software program (Stratagene Cloning Systems, La
Jolla, CA).

Total RNAs per lane were adjusted with the ~-actin bands and

percentage of change in cytokine RNA levels in mycotoxin- treated mice were
calculated using control values set at 1.
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IL-2, IL-3, and IFNy and

~-ac tin

were analyzed by reverse tra nscriptase-

polymera se chain reaction (RT-PCR) using Oligo 4.0-software-selected primer
sets for each sequence as follows:
IL-2 (611 bp):

Sense= 5'-GCGCACCCACTTCAAGCTCC-3'
Antisense= 5' AGCCCTTGGGGCTT ACAAAA-3' .

IL-3 (567 bp):

Sense= 5'-CCCTTGGAGGACCCAGAAC-3';
Antisense= 5'-GCCATGAGGAACA TTCAGAC-3'.

lFNy (510 bp):

Sense= 5'-GTTCTGGGCTTCTCCTCCTG-3';
Antisense= 5'-CGAA TCAGCAGCGACTCCTT -3'.

~-a ctin

(265 bp):

Sense=AACACAGTGTTGTCTGGTGG-3';
Antisense= 5'-ACGCAGCTCAGT AACAGTCC-3'

Fo r first-strand synthesis, 1 !lg of lymphocyte total RNA and 0.5 !lg oligo
(dTh2-18 (GibcoBRL) were mixed in a 20 f!l total volume reaction containing 50
mM Tris-HCI (pH8.3@RT), 75 mM KCI, 3 mM MgCl2, 10 mM OTT, 0.5 mM each
dATP, dCTP, dGTP, and dTTP (Promega), and 200U SuperScript II RNase H- RT
(GibcoBRL) and incubated at 42°C for 50 min. After heating at 70°C for 15 min,
the mixture was chilled in ice, and 2 units of RNaseH (Boehringer Mannheim,
Indianapolis, IN) were added, followed by a 20-min incubation at 37°C. Twenty
microliters of sterile double-distilled water was then added to the eDNA and 2f!l
of the diluted samples were used for each polymerase chain reaction.

The
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optimal MgCI2 and primer concentra tions in a PCR reaction were determined
empirically for each cytokine as follows: MgCI2: IL-2 and ()-actin= 3mM; IL-3 and
IFNy= 2mM; Primer concentration: IL-2 and IL-3= 30 pmol; IFNy= 20 pmol;

P-

actin= 10 pmol. Amplification was done in a TemCyclerll thermocycler (Coy
Lab. Inc., Ann Arbor, MI) as follows: hot start at 95°C for 30 sec, followed by 25
cycles a t 94°C, 30 sec; 55°C, 30 sec; 72°C, 1 min.
The amplification products were run on 2% agarose gels, visualized by
ethidium bromide staining, photographed using Polaroid 667 fi lm, and
quantitated by scanning the negatives as described for Northern blots.

Cytokine quantitation. Supernatants from macrophage cultures activated
for 24 hr were used to quantitate IL-Ia, IL-6, and TNF.

Supernatants fro m

splenocy te cultures activated for 48 hr were used to quantitate IL-2, IL-3 and IFN
yAll supernatants were frozen and maintained at -70°C until assayed. All
cytokines were quantitated by ELISA, using kits from either Genzyme
Diagnostics, Cambridge, MA (IL-l a, IL-2, IL-6, TNF, and IFNy) or Endogen, Inc.,
Cambridge, MA (IL-3) per manufacturer's instructions.

Statistical methods. Data from these studies were analyzed by one-way
analysis of variance (ANOV A) followed by the Fisher PLSD.

Statistical

calculations utilized Stat view TM SE + Graphics software from Abacus Concepts,
Inc.
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RESULTS
Organ weight determination and cell counts revealed a significant
reduction in thymus weight at all doses of T-2 toxin (Table III-1). In contrast,
significant higher values were noted in the weight of the spleen at the medium
(0.5 mg T-2 toxin/kg body weight) and high (2.5 mg T-2 toxin/kg body weight)
doses, and in the liver at the high dose. In addition, a significant increase in
white blood cell counts occurred at the medium dose, and a significant reduction
of red blood cells at the high dose of T-2 toxin. Kidney weights were unaffected
at all doses administered. Thus, it appears that the mycotoxin has an effect in all
immunogenic systems measured, the type and extent depending on the dosage.
The thymus seems to be particularly sensitive to the effect of the toxin.
The effect of T-2 toxin on IL-2, IL-3, and IFNy gene expression was
determined by RT-PCR analysis of total mRNA extracted from splenic
lymphocytes of treated and untreated animals, after 12 hr activation with LPS in
vitro (Figs. III-1-3). IL-2 and IFNy mRNA were significantly increased at the low

and high concentrations of the toxin. There was also an increase of these mRNAs
at the medium dose level, but the increase was not significant (Figs. III-1 and 3).
IL-3 mRNA levels were increased, significantly from the control groups only at
the medium dose of the toxin (Fig. III-2). The levels of P-actin mRNA were
similar in all the groups.
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TABLE III-1
Selected organ weights and blood cell counts of CD 1 mice exposed to
T-2 toxin for two weeks a

Organs (g/100 g body weight)
RBC

T-2 toxin
(mg/ kg) Liver

Kidney

WBC

Spleen

0

5.77 ± 0.23 1.85 ± 0.12

0.30 ± 0.02 0.25 ± 0.02 8.33 ± 0.32 5.75 ± 0.30

0.1

6.05 ± 0.10 1.65 ± 0.07

0.39 ± 0.01 0.19 ± 0.01 * 8.67 ± 0.13 6.19 ± 0.50

o.s

6.13 ± 0.18 1.74 ± o.1o

oAo ± o.o2* 0.20 ± o.o2· 8.37 ± o.23 6.69 ± o.s5*

2.s

6.6o ± o.o8* 1.8o ± 0.10

0.48 ± o.o6* 0.14 ± o.o2* 7.16 ± o.24* 5.05 ± o.38

n Values are given as mean± S.E.M., n=5
*Significantly different from the control valve (p < 0.05)
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FIG. III-1. Effect of T-2 toxin on the Con A-induced IL-2 expression.
Total RNA (111g) of the Con A-activated (Silg/2x106 cells for 12 hr)
splenocytes from control and T-2 toxin-treated mice were used to
make eDNA and amplified by RT-PCR using murine IL-2 and murine
!3-actin primers( A). Band densities from three different animals were
measured from the negatives of the ethidium bromide stained 2%
agarose gels by Zero D-scan. Values of the total PCR product per lane
were measured and equalized using !3-actin standards, and the total
IL-2 PCR product in the treated groups was calculated as percent of
control values(B). Data points were mean ±.S. E. (n=3). (*)Differences
significant at p 5. 0.05 level.
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FIG. Ill-2. Effect of T-2 toxin on the Con A-induced IL-3 expression.
Total RNA (1 J.Jg) of the Con A-activated (5 J.Jg/2x1Q6 cells for 12 hr)
splenocytes from control and T-2 toxin-treated mice were used to make
eDNA and amplified by RT-PCR using murine IL-3 and murine !3-actin
primers (A). Band densities from three different animals were measured
from the negatives of the ethidium bromide stained 2% agarose gels
by Zero D-scan. Values of the total PCR product per lane were measured
and equalized using !3-actin standards, and the total IL-3 PCR product
in the treated groups was calculated as percent of control values (B).
Data points were mean± S. E. (n=3). (•) Differences significant at
p 5. 0.05 level.

101

--

A.

1 - • -STIS't

2.5

0

B.

;-

z
0==

0
...0..

125

u

~
2

0.5

!lilfW;
0.1

~ ~actin

T-2 toxin (mg/kg)

175
150

~

rtlfM

200

u;::l

-a

~ IFNy

100

~

75

~

c
0

u
~
0

50
25
0

0

0.1

0.5

2.5 T-2 toxin (mg/kg

FIG. 111-3. Effect of T-2 toxin on the Con A-induced IFNyexpression. Total
RNA (1 ~-~g) of the Con A-activated (5 ~-~g / 2xl0 6 cells for 12 hr) splenocytes
from control and T-2 toxin-treated mice were used to make eDNA and
amplified by RT-PCR using murine IFNyand murine ~actin primers (A).
Band densities from three different animals were measured from the
negatives of the ethidium bromide stained 2% agarose gels by Zero D-scan.
Values of the total PCR product per lane were measured and equalized
using ~actin standards, and the total IFNyPCR product in the treated
groups was calculated as percent of control values (B). Data points were
mean ±. S. E. (n=3). (*) Differences significant at p ~ 0.05 level.
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Interleukin-la, IL-6, and TNF gene ex pression in thioglycolate-brothstimulated, T-2 toxin-treated and untreated animals was determined by
Northern blot analysis utilizing the total mRNA extracted from macrophages
after 6 hr LPS induction in vitro (Figs. ITI-4-6). There was a significant reduction
in the number of peritoneal macrophages obtained from the high-dose group
(Table rn-2); therefore, not enough total RNA became available for Northern
analysis. For this reason, the total RNA extracted from three different animals in
the high-dose group was pooled and trea ted as a single value; thus the results for
that group could not be statistically evaluated.

The medium and low dose

groups show large variations and the values obtained for all three cytokines
we re not significantly different from the control groups. No marked difference
in the levels of P-actin was observed among the groups.
The effect of T-2 toxin on the cytokine protein production was analyzed
by ELISA. The supernatants of splenocyte cultures from treated and untreated
animals were collected after 48 hr activation with Con A and used to quantitate
IL-2, IL-3 and IFNy. Figures Ill-7 to 9 show that all three cytokine protein levels
increased in general at all doses administered; for IL-2 (Fig. III-7) and IFNy (Fig.
III-9), these increases were significant at the low dosage only. For IL-3 (Fig. Ill-8),
both the low and medium dosages registered a significant increase in protein
secreted into the medium.
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FIG. III-4. Effect of T-2 toxin on the LPS -induced IL-1a expression.
Total RNA (10 ~)of the LP5-activated (10 ~ / 1x1()6 cells for 6 hr)
peritoneal macrophages from control and T-2 toxin-treated mice were
analyzed by Northern blot using murine IL-1a and human !)-actin
32 P-labeled riboprobes in separate experirnents(A). Band densities
from three different animals were measured in medium and low dose
groups and density from high dose group was measured from the
mixture of three animals by Zero 0-scan. Values of the total RNA per
lane were measured and equalized using !)-actin standards, and the
total IL-1a rnRNA in the treated groups was calculated as percent of
control values(B). •Data points are mean± S. E. (n=3) from medium
and low dose group mice. "Single data point was from high dose group
mice.
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FIG. III-5. Effect of T-2 toxin on the LPS -induced TNF expression.
Total RNA (10 J.Jg) of the LPS-activated (10 J.Jg/lx1Q6 cells for 6 hr)
peritoneal macrophages from control and T-2 toxin-treated mice were
analyzed by Northern blot using murine TNF and human 13-actin
32
P-labeled riboprobes in separate experiments(A). Band densities
from three different animals were measured in medium and low dose
groups and density from high dose group was measured from the
mixture of three animals by Zero D-scan. Values of the total RNA per
lane were measured and equalized using 13-actin standards, and the
total TNF mRNA in the treated groups was calculated as percent of
control values(B). •Data points are mean ±S. E. (n=3) from medium
and low dose group mice. bSingle data point was from high dose group
mice.

105

A.

0

B.

2.5

•

IL-6

.

13-actin

0.5

0.1 T-2 toxin (mg/kg)

0.5

2.5 T-2 toxin (mg/kg)

200

"'

~

0 150

"'

QJ

>

~

<
~

100

0
.t:
c

50

E

0

u

?!2-

0

0

0.1

FIG. III-6. Effect of T-2 toxin on the LPS -induced IL-6 expression.
Total RNA (10 J.Jg) of the LPS-activated (10 J.Jg/ 1x106 cells for 6 hr )
peritoneal macrophages from control and T-2 toxin-treated mice were
analyzed by Northern blot using murine IL-6 and human j3-actin
32
P-labeled riboprobes in separate experiments( A). Band densities
from three different animals were measured in medium and low dose
groups and density from high dose group was measured from the
mixture of three animals by Zero 0-scan. Values of the total RNA per
lane were measured and equalized using j3-actin standards, and the
total IL-6 mRNA in the treated groups was calculated as percent of
control values(B). •Data points are mean± S. E. (n=3) from medium
and low dose group mice. bSingle data point was from high dose group
mice. ·
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TABLE III-2
Effect of T-2 toxin on the number of peritoneal
macrophages in CD-1 mice when
exposed for two weeks a

T-2 toxin
(mg/ kg)

macro phages
(x104 / ml)

0

196.4 ± 31.23

0.1

228.4 ± 23.00

0.5

249.0 ± 9.30

2.5

55.6 ± 8.70 *

a Values are given as mean± S. E. (n=S).

*Significantly different from the control values (p < 0.05) .
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Fig. III-7. Effect of T-2 toxin on IL-2 production. Splenocytes
(2x106 /ml) from control and T-2 toxin-treated mice were activated
with 5 Jlg/ml Con A for 48 hrs. Interleukin-2 in culture supernatants
was detected by ELISA. Data were mean± S. E. (n=4). (*) Significant
difference at 0.05 level between treatment and control groups.
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Fig. III-8. Effect of T-2 toxin on IL-3 production. Splenocytes
(2x106 /ml) from control and T-2 toxin-treated mice were activated
with 5 !lg/ ml Con A for 48 hrs. Interleukin-3 in culture supernatants
was detected by ELISA. Data were mean ±S. E. (n=4). (*)Significant
·
difference at 0.05 level between treatment and control groups.
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Fig. III-9. Effect of T-2 toxin on IFNyproduction. Splenocytes
(2x1CJ6/ml) from control and T-2 toxin-treated mice were activated
with 5~~g/ml Con A for 48 hrs. Interferon yin culture supernatants
was detected by ELISA. Data were mean± S. E. (n=4). (*) Significant
difference at 0.05 level between treatment and control groups.
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At the low dosage, the pattern of protein production for IL-2 and INFy
follows closely that observed for the corresponding mRNA levels (see Figs. Ill-1,
3).

At the medium and high dosages, the higher levels of both mRNA and

proteins for these cytokines is maintained, but the protein values do not appear
to differ singnificantly from the controls. IL-3 mRNA and protein levels both
increase, and the increase is significant for the protein at the low and medium
dosages of the toxin.

In general, it seems that T-2 toxin treatment results in

increases of both mRNA and protein levels for IL-2, IL-3, and IFNy, depending
on the dose. The regulation of gene expression at the transcriptional level is
maintained at low doses for IL-2 and IFNy, but not for IL-3, where protein levels
secreted into the medium are significantly increased without a corresponding
increase in mRNA. At the medium and high doses, the correspondence between
mRNA and protein levels is further broken down for all three cytokines, but all
register increases in both mRNA and protein levels when compared to the
control groups.
Similar ELISA analysis was performed for IL-1a, IL-6, and TNF using the
supernatant from macrophage cultures after LPS induction for 24 hr in vitro
(Figs. III-10-12).

The levels of protein for all three cytokines secreted in the

medium are significantly reduced at all dose levels, except for the IL-1a level
found at the medium dose, which, although reduced, does not differ significantly
from control values (see Fig. III-10).
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Fig. III-10. Effect ofT-2 toxin on IL-Ia production. BIG-stimulated
peritoneal macrophages (lx106/ml) from control and T-2 toxin-treated
mice were activated with 10 J.Lg/ml LPS for 48 hrs. Interleukin-la
in culture supernatants was detected by ELISA. Data were mean± S. E.
(n=3). (*)Significant difference at 0.05 level between treatment and ·
control groups.
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Fig. III-11. Effect of T-2 toxin on TNF production. BTG-stimulated
peritoneal macrophages {lx106 /ml) from control and T-2 toxin-treated
mice were activated with 10 ~ / ml LPS for 48 hrs. Tumor necrosis
factor in culture supernatants was detected by ELISA. Data were mean
± S. E. (n=3). (*) Significant difference at 0.05 level between treatment and
control groups.
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Fig. III-12. Effect of T-2 toxin on IL-6 production. BIG-stimulated
peritoneal macrophages (lx106 /ml) from control and T-2 toxin-treated
mice were activated with 10 J.!g/ml LPS for 48 hrs. Interleukin-6
in culture supernatants was detected by ELISA. Data were mean ± S. E.
(n=3). (*)Significant difference at 0.05 level between treatment and ·
control groups.
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Thus, T-2 toxin treatment in general seems to have a variable effect on IL-l

a , TNF, and IL-6 mRNA, and to significantly decrease the amount of protein
secreted into the medium at all dose levels.

DISCUSSION
This study measured the effect of T-2 toxin on the genetic expression of
certain key cytokines and is based on the assumption that the analysis of the
toxin-induced changes in the pattern of gene expression will help to elucidate the
molecular mechanisms whereby the toxin exerts its immunosuppressive effects.
Low and repeated doses of T-2 toxin were administered in vivo and both mRNA
and protein levels of cytokines IL-2, IL-3, and IFNy in splenocytes, and cytokines
IL-la, IL-6, and TNF in macrophages were measured after activation of the
purified populations with Con A and LPS, respectively, in vitro.
The high dose of T-2 toxin seems to be relatively more toxic; it increased
both liver and spleen weights and RBC counts, and decreased the thymus
weights significantly. Similar results were observed in other studies (Taylor et
al., 1989; Dugyala et al., 1994). In addition, the relative spleen weights and WBC

counts of medium-dose-treated animals increased significantly while at the same
dose the thymus weights significantly decreased when compared to the control
groups; this shows that T-2 toxin affects both the central and peripheral
lymphoid organs studied. A decrease of thymus weights at all doses may be due
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to cortical depletion (Taylor et al., 1989). Balanced semipurified diet containing
T-2 toxin (20 ppm) fed to mice for 6 weeks showed hyperplastic spleens (Hayes et
al., 1980).

The changes in the spleen were mainly in the red pulp involving

proliferation of myeloid components, including erythroid and granulocytic
precursors (Taylor et al., 1989). In the present study, the number of brewers
thioglycolate broth-activated peritoneal macrophages collected in the high-dosetreated mice was dramatically reduced (4-fold less than the controls). T-2 toxin is
more toxic when given by the dietary route than when given by other routes in
many species (Ohtsubo and Saito, 1977; Chi et al., 1977; Richard et al., 1978;
Weaver et al., 1978; Hayes et al., 1980). In these studies, T-2 toxin consistently
caused reduced food consumption, reduced growth rates, and inflammatory
lesions around the mouth and in the upper alimentary tract. Similar kinds of
symptoms were observed in the present study. In one study (Taylor et al., 1989),
the histopathalogy of male CD-1 mice treated with a high dose (2.5 mg/kg body
wt) of T-2 toxin for 2 or 4 weeks included ulcers, partially calcified in the
proximal portion of the cardia, with influx of mononuclear infiltration.

The

reduced number of peritoneal macrophages collected in the high-dose-treated
groups in the present study may be due to their accretion in the inflammatory
regions.

Moreover, T-2 toxin has proven to be cytotoxic to many cell types

(Gerberick and Sorenson, 1983; Holt et al., 1988a; Dugyala et al., 1994). T-2 toxin
(0.1- 0.89 J.lM for 20 hr in vitro) decreased cell viability, cell number, and viability
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index in alveolar macrophages of rats and showed pseudopodia, cellular
bl ebbing, smoothing of membrane processes, and cell lys is when observed by
scanning electronmicrosopy (Gerberick and Sorenson, 1983).
There is general induction of IL-2 and IFNy mRNA levels in Con Aactivated splenocytes in vitro in all doses of T-2 toxin-treated mice; the values are
significantly higher than controls in the low and high doses. For IL-3, mRNA
levels are significantly higher than controls at the medium dose. It clearly shows
tha t T-2 toxin directly or indirectly induces the mRNA levels of these cytokines
either a t the transcriptional or post-transcriptional level. The protein levels of all
three cytokines are also increased, significantly so for IL-2 and IFNy at low
dosage, and for IL-3 at the low and medium dosages. There is a correspondence
between mRNA and protein levels for IL-2 and IFNy in the low-dose-treated
mice. This is an indication that at low dosage the toxin does not alter the usual
transcriptional regulation of IL-2 and IFNy expression However, in the highdose-treated mice, protein levels for these cytokines do not correlate with the
induced mRNA levels. One possible explanation is that T-2 toxin at the medium
and high doses is superinducing mRNA levels by stabilizing the message for
these cytokines while reducing the efficiency of translation or post-translational
modification of the proteins. The pattern of protein expression for IL-3 does not
correspond to the mRNA levels measured at any of the dosages of the toxin;

117
thus, for this cytokine, the usual transcriptional regulation is also affected by the
toxin.
CD4+ T cells are subdivided into two distinct subsets based on the pattern
of lymphocyte secretion; TH1 cells produce IL-2 and IFNy (and other cytokines)
but not IL-4, IL-5, IL-6, and IL-10.

These cells are involved in cell-mediated

immune responses. On the other hand, TH2 cells produce IL-4, IL-5, IL-6, and IL10, but not IL-2 and IFNy; they are involved in antibody-mediated immune
responses. IL-3 is produced by both types of subsets (Mosmann and Coffman,
1989). This division of labor among T-helper cells determines whether humoral
or cell-mediated immunity will predominate following their first encounter with
antigen. The high levels of IL-2 and IFNy measured after the low-dose treatment
is an indication that, at that dosage, T-2 toxin may increase cell-mediated
immunity.

This does not necessarily translate into an enhanced immune

response since, in order to be effective, these cytokines must interact with their
target cells and these, in turn, may be impaired by other toxin-induced
alterations, such as those found in the macrophages to be discussed below.
It

is

known

that

these

cytokines

transcriptionally and post transcriptionally.

are

tightly

regulated

both

Interleukin-2, IL-3, and IFNy

cytokine genes share a consensus element, IT ATTT AT, located in the 3'
untranslated region, which is believed to confer instability to the transcripts
resulting in their rapid degradation (Campbell et a/., 1985; Caput et a/., 1986;
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Shaw and Karmen, 1986). Cyclohexamide (CHX), a protein synthesis inhibitor,
has been shown to superinduce IL-2 and IFNy mRNA. The superinduction is
presumably due to stabilization of the mRNA because of CHX inhibition of
RNase synthesis responsible for the specific degradation of the unstable
transcripts (Cockfield and Ramassar, 1991; Zubiaga et al., 1991; Cockfield et al.,
1993). The observation that T-2 toxin increases mRNA levels of IL-2, IL-3 and
IFNy and that it, in general, increases the levels of secreted protein in the
medium suggests that its action resembles that of CHX.

Vomitoxin, another

trichothecene, produced by Fusarium graminearum, also superinduced the
production of IL-2, IL-4, IL-5, and IL-6 mRNA and protein levels in EL4.1L-2
thymoma cell line in vitro (Dong et al., 1994). A 4-fold increase in IL-2 levels was
observed in Con A-activated splenocytes in vitro from mice dosed for four
consecutive doses of 2 mg/ kg T-2 toxin (Holt et al., 1988b). Enhanced resistance
to such infections as Listeria monocytogens due to preinoculation treatment with
T-2 toxin in some studies (Carrier and Ziprin, 1986; Carrier et al., 1987) can be
partially explained as being due either to the capacity of T-2 toxin to induce IL-2,
IFNy, IL-3 and increase cell mediated immunity, or to an increase of phagocytic
activity of macrophages. However, T-2 toxin immunotoxicity definitely depends
on its dose and duration of exposure in the mice. T-2 toxin treatment (0-2.5
mg/ kg) every third day in CD-1 mice for 2 weeks increased PHA-induced
stimulation in vitro in splenocytes in low-dose-treatment groups and suppression
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in high-dose-treatment groups in splenic lymphocy tes, and no significant
differences were observed when the treatment extended to 4 weeks (Taylor et al.,
1985). T-2 toxin is also known to decrease resistance to infections (Kanai and
Kondo, 1984; Carrier and Ziprin, 1986) and cause a decrease in cell and humoralmediated immunity (Rosenstein et al., 1979; Taylor et al., 1985). Activation or no
effect of the IL-2, IFNy, and IL-3 gene expression due to T-2 toxin exposure in the
present study shows that T-2 toxin-induced immunosuppression may not be due
to alteration of these cytokines, but some other mechanism. Thymic atrophy,
depletion of T lymphocytes, and prolymphiod population in fetal thymocy tes
(Hayes et al., 1980; Hunter et al., 1985; Taylor et al., 1989; Holladay eta/., 1993;
Holladay et al., 1995) due to the T-2 toxin exposure in mice shows that T-2 toxin
is specifically lymphocytolytic.

Even though elevated levels of cytokines are

observed, lack of enough responding cells to the specific cytokines may cause
immunosuppression.
T-2 toxin seems to have a profound effect on the macrophage-produced
cytokines when activated with LPS in vitro.

As pointed out earlier in the

discussion, there was a reduction in the number of macrophages in the highd ose-treated groups, which may be due to the concentration of macrophages in
the inflamatory sites, rather than their accumulation in the peritoneal fluid . The
total mRNA was pooled and analyzed as a single group. This group of animals
showed a slight decrease in the TNF mRN A when compared to the controls even
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though the decrease cannot be evaluated statistically. In general, T-2 toxin does
not seem to affect the mR NA levels of IL-1a, IL-6, and TNF but inhibits the
secreted protein levels in all doses (IL-1a protein is not significantly decreased in
the medium dose group).

The data show that in the macrophage, the toxin

regulates the expression of the cytokines measured mainly at the translational or
post-translational level.
T-2 toxin is known to be a protein synthesis inhibitor in immune cells
(Gyongyossy-lssa and Khachatourians, 1984; Rosenstein and Lafarge-Frayssinet,
1983). This inhibition may be due to direct action of the toxin on the protein
sy nthesizing machinery of the cell, or it could be acting indirectly via some other
pathway, i.e., the stress-related response involving the HPA axis. Evidence for a
direct effect of the toxin on protein synthesis was obtained by Cundliffe et a/.
(1974), who showed that T-2 toxin impairs polypeptide chain intiation by causing
disaggregation of the polyribosomes.

It is also known that trichothecenes,

including T-2 toxin, bind to ribosomes and thereby inhibit peptidyl transferase
and block intiation of polypeptide synthesis (Melmed and Yagen, 1985). Indirect
action of T-2 toxin on the macrophage cytokine production is also substantiated .
Endotoxemia is observed 24 hr after male CD-1 mice received a single oral dose
of T-2 toxin (2.5-20 mg/ kg) coinciding with the increase of corticosterone levels
(Taylor e( a/., 1989). Endotoxemia in male Swiss mice following treatment with
T-2 toxin (4 mg/ kg) was found to be due to increased absorption of endotoxin,

an

outer

membrane

component of

gram-negative

gastrointestinal tract (Taylor et al., 1991).

bacteria,

from
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the

Even though they observed the

increased levels of endotoxin and corticosterone levels in the higher
concentration of the toxin, it is possible that these levels may also be increased in
all doses used in this study. Corticosterone is known to selectively deplete the
thymic cortical cells in mice (Carroll et al., 1969).

This correlates with the

significant decrease in thymic weights in all doses observed in this study,
indicating that there is a hormonal imbalance due to a stress response associated
with systemic endotoxemia.
Endotoxin tolerance is the phenomenon developed by the host to survive
and elicit controlled inflammatory responses due to a localized stimulus,
resulting in repeated insult with the endotoxin (Zuckerman et al., 1991). It is
possible that in the present study, peritonial macrophages became tolerant due to
endotoxernia in vivo, thus becoming unable to secrete the cytokines upon further
activation with LPS in vitro.

Regulation of TNF expression in peritoneal

macrophages that were refractory following repeated in vitro exposure to LPS
has been demonstrated to occur at a post-translational level (Zuckerman et al.,
1989). Involvement of glucocorticoid hormones in this process has been shown

(Beutler et al ., 1986). IL-l translation is also suppressed in LPS-activated U937
cells in vitro when exogenous prostaglandins (PGE2) were added, via increase of
cellular cAMP levels (Knudsen et al., 1986). Endotoxin treatment is known to
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increase PGE2 synthesis in monocytes (West eta/., 1993). Corticotropin releasing
factor induces not only the release of adrenocorticotropic hormone by the
pituitary, which induces coticosterone via the HPA axis in adrenals, but also the
release of catecholamines such as norepinephrine from adrenal medulla (Fuchs
and Sanders, 1994). Norepinephrine seems to increase cAMP levels (Krammer,
1988). It is possible that the 3' untranslated sequence (TT ATIT AT), which is
conserved in pro-inflammatory cytokines (Brown and Beutler, 1990), may be
regulated translationally through a cAMP-dependent signal transduction
mechanism.
In conclusion, T-2 toxin appears to affect cytokine production by
lymphocytes and macrophages differentially.

The lymphocyte-produced

cytokine mRNA and protein levels are generally increased, and the macrophageproduced cytokines are suppressed at the protein levels. The decrease in protein
levels observed in the macrophage may be due to a direct effect of the toxin on
the protein synthetic machinery of the cells, or an indirect response through a
stress-related mechanism. The immunosuppression caused by the toxin may be
due to the impairment of macrophage functions, or to the fact that, even in the
presence of increased amounts of cytokine proteins (IL-2, IFNy, or IL-3), cytolytic
action or impairment of membrane function by the toxin on effector cells, c.f.,
macrophages, cytotoxic/helper T cells, NK cells, etc., obviates the production of
a full immune response.
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CHAPTER IV
SUMMARY

Mycotoxins are secondary fungal metabolites; they are ubiquitous in the
environment and have a wide range of toxic effects, including immunotoxicity to
humans as well as domestic and laboratory animals. Aflatoxin 8 1 is produced by
several strains of aspergillus species and T-2 toxin is produced by the fusarium
species. lmmunotoxicity of both toxins is mediated by their influence upon nonspecific immune processes such as adherence, phagocytosis, and chemotaxis by
macrophages and other heterophils. Cell- and humoral-mediated immunity are
modulated by affecting mainly T-helper cell functions. This would inhibit
delayed-type hypersensitivity; cytotoxicity by NK, CTL, and macrophages; and
T-dependent antibody production. Interestingly, many of the above mentioned
immune functions are controlled by growth factors collectively known as
cytokines. Little information is known about the modulation of cytokine gene
expression by the mycotoxins, specifically, whether they influence their
transcriptional and/ or translational regulation.
The present study investigated the molecular events involved in AFBJand T-2 toxin-induced immunotoxicity in male CD-1 mice by measuring gene
expression of cytokines produced by peritoneal macrophages

(IL-la, TNF, and

IL-6) and lymphocytes (IL-2, IL-3, and IFNy). Messenger RNA and protein levels
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were measured in LPS-activated macrophages and Con A-activated lymphocy tes
in vitro: Cytokine-specific mRNAs were identified and quantified by Northern

blot/ RT-PCR techniques, and protein levels were measured by sandwich ELISA.
Male CD-1 mice received either 0 (control), 0.03 (low dose), 0.145 (medium dose),
and 0.7 (high dose) mg/kg body weight of AFB1 , or 0 (control), 0.1 (low dose), 0.5
(medium dose), and 2.5 (high dose) mg/ kg body weight of T-2 toxin, by oral
gavage every other day for 2 weeks (seven doses).
The results clearly show that the toxicology and alteration of cytokine
expression of AFB1 and T-2 toxin are entirely different. Aflatoxin B1 has no effect
on the weights of the organs selected but does have a significant increase in the
WBC count in the low-dose-treated group. T-2 toxin significantly suppressed the
thymus weights in all groups, and increased the spleen weights in medium- and
high-dose-treated groups. A significant increase of liver weight, and an increase
of RBC counts in high dose and WBC counts in medium dose show that T-2 toxin
affects some of the vital organs of the body. A 4-fold decrease in the total
number of macrophages collected in high-dose-treated T-2 toxin group confirms
that T-2 toxin is toxic in the high-dose-treated mice.
Con A-induced production of cytokine profile from AFB1-treated mice
splenocytes is different from the cytokines produced from T-2 toxin-treated mice.
A significant decrease of IL-2 mRNA and a pattern of slight decrease in IFNy and
IL-3 mRNA in the low-dose-treated AFB1 groups are observed. Protein levels of
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these cytokines followed the pattern of mRNA of the respective cytokine; this
shows that there is no decoupling of mRNA and protein synthesis. These results
show that AFB1 did not have much effect on the expression of these cytokines. A
slight decrease of these cytokines in the low dose-treated group may be due to
the activation of inhibitory factors for TH 1-producing cytokines.
T-2 toxin, on the other hand, induced the IL-2, IFNy, and IL-3 mRNA
expression in in vitro Con A-activated splenocytes.

Interleukin-2 and IFNy

mRNA were induced significantly in high- and low-dose-treated mice, and IL-3
mRNA is induced in medium-dose-treated mice. Protein levels of IL-2 and IFNy
followed the mRNA levels in the low dose but not in the high dose.

These

results suggest that T-2 toxin is either increasing the transcription or stabilization
of mRNA in the low- and high-dose-treated mice and at the same time
interfering with the protein synthesis or secretion of these cytokines in the highdose-treated-mice.

lnterleukin-3 protein levels are significantly high in the

medium and low dose even though there is no significant increase in the mRNA
levels in the low-dose-treated mice, suggesting that T-2 toxin also increases the
translational or post-translational efficiency.

These results also reveal that

cytokines are modulated differentially by these toxins.
Lipopolysaccharide-induced IL-la, TNF, and IL-6 gene expression in
peritoneal macrophages is also modulated differently by both toxins in exposed
mice.

Messenger RNA expression of both IL-la and TNF was suppressed
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significantly in high dose and increased significantly in low and medium dose,
res pectively, in AFB1-treated mice.

Protein of both cytokines decreased

significantly in accordance with the mRNA. lnterleukin-la protein is strongly
suppressed also in low- and medium-dose-treated mice. lnterleukin-6 mRNA is
increased significantly in the medium dose group and there is a general d ecrease
the protei n in all doses, which is significant in high-dose-treated groups.
Aflatoxin B1 seems to modulate both mRNA and protein levels differently in all
groups. Suppression or activation of mRNA levels by AFB1 may be due to
modul a tion of factors responsible for transcription or mRNA stability. Strong
suppression of IL-la protein in all groups of treated mice is a very interesting
result because of the unique mechanism of processing and secretion of IL-l a
when compared to the other pro-inflammatory cytokines.
There are no significant differences in the mRNA levels of IL-la, TNF,
and IL-6 in LPS-activated peritoneal macrophages of low- and medium-dosetreated T-2 toxin mice. Significant levels could not be assessed statistically in the
high-dose-treated group because pooled RNA from three animals is used as a
single group due to lack of sufficient RNA. However, a slight decrease in TNF
mRNA was observed with no difference in the other two cytokines in the highdose-treated mice. Protein levels in all cytokines are suppressed significantly
(except IL"la in medium dose) in all treated doses; this shows that T-2 toxin has
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more of an effect at the translational or post-translational level in a nonspecific
manner.
In short, AFB1 and T-2 toxin differ in the way they modulate cytokine
expression in CD-1 mice. Based on these results and others, AFB1 may modulate
the cell-mediated responses, inhibiting the macrophage-producing cytokines and
other functions, thereby stopping the signals toT-helper cells. T-2-toxin-induced
immunosuppression may also be due to the inhibition of cytokines produced by
the macrophages, but lack of effector cells to respond to the cytokines (IL-2, IFNy, and IL-3) is also an important factor in the mechanism of immunosuppression

of T-2 toxin. Figure IV-1 presents a summary based on the present data of the
possible mechanisms through which AFB1 and T-2 toxin modulate cytokine gene
expression.
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